Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside-To The Moon - Tiger Brokers Online Investing Community

210
17
Favorite

Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside

CNBC2021-08-02

Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

210

Report

Comment（17）

calbee_lwh
·2021-08-02
Ok
Reply
Like
Report
Venus168
·2021-08-02
Buy buy buy[財迷]
Reply
1
Report
Dreamchaser9
·2021-08-02
Cool tips
Reply
1
Report
BlueDragon
·2021-08-02
Nice and like
Reply
2
Report
xiaobaii
·2021-08-02
like & comment please, thank you very much
Reply
8
Report
Fold Replies
- Dreamchaser9:
  Done
  2021-08-02
  Reply
  Report
Jerronlyq
·2021-08-02
Niceee
Reply
3
Report
Fold Replies
- xiaobaii:
  like & comment please, thank you very much
  2021-08-02
  Reply
  Report
- TraderBoss28:
  Noted
  2021-08-02
  Reply
  Report
NareshwG
·2021-08-02
They need to promote in order to earn commission. So, we have to be careful and take the ideas with a pinch of salt..
Reply
7
Report
Fold Replies
- NareshwG:
  All the best to you =)
  2021-08-02
  Reply
  Report
- xiaobaii:
  like & comment please, thank you very much
  2021-08-02
  Reply
  Report
- hlw8888:
  that's true... wallet limited.
  2021-08-02
  Reply
  Report
Bptan1973
·2021-08-02
Jd my favorite stock
Reply
4
Report
Fold Replies
- xiaobaii:
  like & comment please, thank you very much
  2021-08-02
  Reply
  Report
KingKong88
·2021-08-02
Hmm... [思考]
Reply
6
Report
Fold Replies
- qstocks:
  like
  2021-08-02
  Reply
  Report
- NareshwG:
  Same here..
  2021-08-02
  Reply
  Report
- xiaobaii:
  like & comment please, thank you very much
  2021-08-02
  Reply
  Report
JennyTan
·2021-08-02
?
Reply
2
Report
Fold Replies
- xiaobaii:
  like & comment please, thank you very much
  2021-08-02
  Reply
  Report
Valerie1209
·2021-08-02
?
Reply
3
Report
Haw75
·2021-08-02
Like
Reply
3
Report
Fold Replies
- gstrader:
  great
  2021-08-02
  Reply
  Report
doubleDees
·2021-08-02
Like please. Thanks
Reply
3
Report
Fold Replies
- Darrenneoyo:
  like
  2021-08-02
  Reply
  Report
Benlaps
·2021-08-02
?
Reply
2
Report
Fold Replies
- Regit126:
  a
  2021-08-02
  Reply
  Report
Roticanai
·2021-08-02
Like
Reply
5
Report
Butt3rc00ki3
·2021-08-02
Like
Reply
6
Report
yani
·2021-08-02
Like and comment pls
Reply
5
Report
Fold Replies
- deneee:
  ok
  2021-08-02
  Reply
  Report
- dotdot112:
  [Strong]
  2021-08-02
  Reply
  Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1125617093?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-08-02 11:40","share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","id":"1125617093","market":"hk","top_or_hot":-1,"title":"Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside","media":"CNBC","content":"<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Source Link</a>\n\n</div>\n","source":"cnbc_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs picks new stocks to buy from tech to health — some with over 100% upside\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 11:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ZM","symbol_name":"Zoom","start_time":0,"source_url":"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html","article_id":"1125617093","we_media_id":null,"thumbnails":[],"rights":{"source":"cnbc_highlight","url":"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.ArticleHeader-headline{#titleStyle#}a{#lv2TextColor#}.ArticleHeader-time, .Author-authorNameAndSocial a{#sourceStyle#;}","selectors":".PageBuilder-pageWrapper","filters":".ArticleHeader-eyebrow, .RelatedTags-relatedTags","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=1125617093","pubTimestamp":1627875620,"sourceInfo":{"source_id":"cnbc_highlight","name":"CNBC"},"weMediaInfo":null,"summary":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health ","collect":0,"end_time":0,"defaultTopTitle":"cnbc.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"ZM":"Zoom","LYV":"Live Nation Entertainment","PVH":"PVH Corp","02171":"科济药业-B","TASK":"TaskUs Inc.","LYEL":"Lyell Immunopharma, Inc.","LULU":"lululemon athletica","LEVI":"李维斯","AMAM":"Ambrx Biopharma Inc","S":"SentinelOne, Inc","02618":"京东物流","GS":"高盛","IHRT":"iHeartMedia, Inc.","IS":"IronSource Ltd","RL":"拉夫劳伦"},"translate_title":"高盛选择从科技到健康的新股票购买--一些有超过100%的上涨空间","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LEVI":0.9,"ZM":0.9,"TASK":0.9,"S":0.9,"RL":0.9,"PVH":0.9,"LYV":0.9,"LYEL":0.9,"LULU":0.9,"02171":0.9,"IS":0.9,"IHRT":0.9,"GS":0.9,"CNVY":0.9,"BHG":0.9,"AMAM":0.9,"02618":0.9},"content_text":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is buy-rated on about 45 — and some have a potential upside of over 100%.\nGoldman’s analysts initiated coverage on newly-listed companies that debuted on the stock market in the past few months, and also started providing research on some big-name apparel and media brands. Here’s a selection.\nHealth care\nU.S. insurance firm Bright Health Group, which operates insurance tech software as well as a platform connecting patients with health providers is buy-rated by the bank and raised nearly $1 billionin an initial public offering (IPO) in May. Goldman said it sees more than 100% upside to the share price from its current levels over 12 months, while trading at a “healthy” discount to other rapidly-growing insurers, according to a July 19 research note.\nGoldman also likes Ambrx Biopharma Inc, a cancer biotech firm, for its “pioneering research”, “unique and differentiated platform technology” and partnerships with pharmaceuticals companies such as Bristol Myers Squibb. The bank’s 12-month price target is $53, representing a 148.8% potential upside, the analysts said in a July 13 research note.\nHealth tech company Convey Holding Parent, Inc., which counts the likes of U.S. government insurance plan Medicare as a customer, is a buy for the bank. “We believe Convey differentiates itself from competitors as a provider of purpose-built healthcare IT software and services to government-sponsored health plans,” Goldman’s analysts wrote in a July 11 research note. The bank’s 12-month price target is $21, representing a potential 112.6% upside.\nLyell Immunopharma, Inc., which develops cancer therapies, is also buy-rated by the analysts. “We are encouraged by the preclinical data seen to-date and the experienced management team and note multiple programs are set to enter the clinic with first-in-human data next year,” Goldman’s analysts said in a July 12 research note. The bank’s 12-month price target is $30, representing a potential upside of 88.9%.\nOther new healthcare stocks Goldman picked include Chinese biotech firm CARSGEN-B, with a 12-month price target of 48.72 Hong Kong dollars ($6.25) — a potential upside of 62.7% — and Chinese firm AmoyDx, with a 12-month price target of 140 yuan renminbi ($21.52), a potential upside of 66.7%.\nTechnology\nDigital support company TaskUs Inc. is buy-rated, with Goldman giving it a 12-month price target of $61, a potential upside of 88.3%. The firm helps manage customer service for the likes of Zoom, which hired the company as the coronavirus pandemic struck in 2020. “We believe there is potential, given its historically high net retention rate, for it to grow above the consensus growth rates of its clients,” the bank’s analysts wrote in a July 6 note.\nGoldman gave IronSource Ltd, a “fast growing mobile ad platform at scaled margins,” a 12-month price target of $11, a potential upside of 23.7%. The company went public in Marchvia a special-purpose acquisition vehicle (SPAC)and the bank said it would benefit from growth in mobile apps and also liked its game development arm Sonic Publishing.\nSentinelOne, Inc, which debuted on the New York Stock Exchange in June and wasthe highest-valued cybersecurity IPO ever, is also buy-rated by the bank. Goldman described it as “a best of breed, founder-led XDR [extended detection and response] leader in one of the most attractive segments within Security Software,” in a July 25 research note. The bank gave the stock a 12-month price target of $57, a potential upside of 22.4%.\nGoldman also picked “leading” Chinese firm JD LOGISTICS— which became a separate entity to retail giant JD.com in 2017 — andlisted on the Hong Kong stock exchange in May. Goldman expects it to double its market share by 2025, growing via investments in supply chain technology, overseas expansion and additions to its air cargo network. The bank’s 12-month price target is 58.50 Hong Kong dollars, representing a potential upside of 38.3%.\nGoldman also likes Nasdaq-listed Turkish e-commerce giant Hepsiburada, with a 12-month price target of $25.90 — a potential upside of 95% — and Chinese electronics seller AiHuiShou, with a 12-month price target of $20.80, representing a potential upside of 48.1%.\nApparel\nGoldman started covering several apparel stocks this month and said the sector has “macro tailwinds from a strong consumer and supportive discretionary retail spend,” in a July 14 note to investors.\nAthleisure company Lululemon Athletica on Goldman’s conviction list, with the bank describing it as “a leader in driving online to offline consumer connection,” giving it a buy rating. The analysts likedits $500 million acquisition of fitness screen company Mirror, and gave the stock a $447 12-month target price, a potential upside of 21%.\nLuxury label Ralph Lauren has “potential upside” from digital sales via its own websites, according to Goldman, which is “upbeat” about the company’s turnaround, and it gave it a buy rating. The bank’s 12-month price target is $147, a potential upside of 28%.\nGoldman is also buy-rated on Calvin Klein owner PVH Corp, due to the company’s e-commerce focus, new management and pandemic restructuring, expecting the firm to provide “stronger” margins. The bank gave the stock a 12-month price target of $127, a potential upside of 21%.\nLevi Strauss & Co is a buy for the bank, which liked its “best-in-class heritage positioning.” “LEVI is emerging from the pandemic with a better-positioned US wholesale marketplace, a more agile organization with increased digital tools and a faster go-to-market,” Goldman said. Its 12-month price target is $36, a potential upside of 25%.\nMedia\nGoldman started covering concert promoter Live Nation Entertainment on July 15. “We initiate coverage on Live Nation (“LYV”) with a Buy rating and 12-month price target of $110, implying 35% total potential return,” the bank said. Goldman expects an uptick inlive events after the pandemicand sees growth opportunities in high-margin merchandise and VIP experiences.\nThe bank also likes audio firm iHeartMedia, Inc., calling it a “most undiscovered” stock, and “the leading multi-platform audio media company in the U.S.” “We initiate coverage on iHeartMedia (“IHRT”) with a Buy rating and a 12-month price target of $32, representing 25% total potential return,” the analysts said in a July 15 research note.","kind":null,"is_publish_news":false,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":804064058,"gmtCreate":1627912846274,"gmtModify":1703497760236,"author":{"id":"3579950492873390","authorId":"3579950492873390","authorIdStr":"3579950492873390","name":"calbee_lwh","avatar":"https://static.tigerbbs.com/2c71feed0eaf38825c4f2fc86cd7a84d","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3579950492873390"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/804064058","repostId":1125617093,"repostType":2,"repost":{"id":"1125617093","pubTimestamp":1627875620,"share":"https://ttm.financial/m/news/1125617093?lang=&edition=fundamental","pubTime":"2021-08-02 11:40","market":"us","language":"en","title":"Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside","url":"https://stock-news.laohu8.com/highlight/detail?id=1125617093","media":"CNBC","summary":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health ","content":"<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs picks new stocks to buy from tech to health — some with over 100% upside\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 11:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"S":"SentinelOne, Inc","LULU":"lululemon athletica","AMAM":"Ambrx Biopharma Inc","LYEL":"Lyell Immunopharma, Inc.","TASK":"TaskUs Inc.","ZM":"Zoom","IS":"IronSource Ltd","02618":"京东物流","LYV":"Live Nation Entertainment","PVH":"PVH Corp","RL":"拉夫劳伦","02171":"科济药业-B","LEVI":"李维斯","IHRT":"iHeartMedia, Inc.","GS":"高盛"},"source_url":"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1125617093","content_text":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is buy-rated on about 45 — and some have a potential upside of over 100%.\nGoldman’s analysts initiated coverage on newly-listed companies that debuted on the stock market in the past few months, and also started providing research on some big-name apparel and media brands. Here’s a selection.\nHealth care\nU.S. insurance firm Bright Health Group, which operates insurance tech software as well as a platform connecting patients with health providers is buy-rated by the bank and raised nearly $1 billionin an initial public offering (IPO) in May. Goldman said it sees more than 100% upside to the share price from its current levels over 12 months, while trading at a “healthy” discount to other rapidly-growing insurers, according to a July 19 research note.\nGoldman also likes Ambrx Biopharma Inc, a cancer biotech firm, for its “pioneering research”, “unique and differentiated platform technology” and partnerships with pharmaceuticals companies such as Bristol Myers Squibb. The bank’s 12-month price target is $53, representing a 148.8% potential upside, the analysts said in a July 13 research note.\nHealth tech company Convey Holding Parent, Inc., which counts the likes of U.S. government insurance plan Medicare as a customer, is a buy for the bank. “We believe Convey differentiates itself from competitors as a provider of purpose-built healthcare IT software and services to government-sponsored health plans,” Goldman’s analysts wrote in a July 11 research note. The bank’s 12-month price target is $21, representing a potential 112.6% upside.\nLyell Immunopharma, Inc., which develops cancer therapies, is also buy-rated by the analysts. “We are encouraged by the preclinical data seen to-date and the experienced management team and note multiple programs are set to enter the clinic with first-in-human data next year,” Goldman’s analysts said in a July 12 research note. The bank’s 12-month price target is $30, representing a potential upside of 88.9%.\nOther new healthcare stocks Goldman picked include Chinese biotech firm CARSGEN-B, with a 12-month price target of 48.72 Hong Kong dollars ($6.25) — a potential upside of 62.7% — and Chinese firm AmoyDx, with a 12-month price target of 140 yuan renminbi ($21.52), a potential upside of 66.7%.\nTechnology\nDigital support company TaskUs Inc. is buy-rated, with Goldman giving it a 12-month price target of $61, a potential upside of 88.3%. The firm helps manage customer service for the likes of Zoom, which hired the company as the coronavirus pandemic struck in 2020. “We believe there is potential, given its historically high net retention rate, for it to grow above the consensus growth rates of its clients,” the bank’s analysts wrote in a July 6 note.\nGoldman gave IronSource Ltd, a “fast growing mobile ad platform at scaled margins,” a 12-month price target of $11, a potential upside of 23.7%. The company went public in Marchvia a special-purpose acquisition vehicle (SPAC)and the bank said it would benefit from growth in mobile apps and also liked its game development arm Sonic Publishing.\nSentinelOne, Inc, which debuted on the New York Stock Exchange in June and wasthe highest-valued cybersecurity IPO ever, is also buy-rated by the bank. Goldman described it as “a best of breed, founder-led XDR [extended detection and response] leader in one of the most attractive segments within Security Software,” in a July 25 research note. The bank gave the stock a 12-month price target of $57, a potential upside of 22.4%.\nGoldman also picked “leading” Chinese firm JD LOGISTICS— which became a separate entity to retail giant JD.com in 2017 — andlisted on the Hong Kong stock exchange in May. Goldman expects it to double its market share by 2025, growing via investments in supply chain technology, overseas expansion and additions to its air cargo network. The bank’s 12-month price target is 58.50 Hong Kong dollars, representing a potential upside of 38.3%.\nGoldman also likes Nasdaq-listed Turkish e-commerce giant Hepsiburada, with a 12-month price target of $25.90 — a potential upside of 95% — and Chinese electronics seller AiHuiShou, with a 12-month price target of $20.80, representing a potential upside of 48.1%.\nApparel\nGoldman started covering several apparel stocks this month and said the sector has “macro tailwinds from a strong consumer and supportive discretionary retail spend,” in a July 14 note to investors.\nAthleisure company Lululemon Athletica on Goldman’s conviction list, with the bank describing it as “a leader in driving online to offline consumer connection,” giving it a buy rating. The analysts likedits $500 million acquisition of fitness screen company Mirror, and gave the stock a $447 12-month target price, a potential upside of 21%.\nLuxury label Ralph Lauren has “potential upside” from digital sales via its own websites, according to Goldman, which is “upbeat” about the company’s turnaround, and it gave it a buy rating. The bank’s 12-month price target is $147, a potential upside of 28%.\nGoldman is also buy-rated on Calvin Klein owner PVH Corp, due to the company’s e-commerce focus, new management and pandemic restructuring, expecting the firm to provide “stronger” margins. The bank gave the stock a 12-month price target of $127, a potential upside of 21%.\nLevi Strauss & Co is a buy for the bank, which liked its “best-in-class heritage positioning.” “LEVI is emerging from the pandemic with a better-positioned US wholesale marketplace, a more agile organization with increased digital tools and a faster go-to-market,” Goldman said. Its 12-month price target is $36, a potential upside of 25%.\nMedia\nGoldman started covering concert promoter Live Nation Entertainment on July 15. “We initiate coverage on Live Nation (“LYV”) with a Buy rating and 12-month price target of $110, implying 35% total potential return,” the bank said. Goldman expects an uptick inlive events after the pandemicand sees growth opportunities in high-margin merchandise and VIP experiences.\nThe bank also likes audio firm iHeartMedia, Inc., calling it a “most undiscovered” stock, and “the leading multi-platform audio media company in the U.S.” “We initiate coverage on iHeartMedia (“IHRT”) with a Buy rating and a 12-month price target of $32, representing 25% total potential return,” the analysts said in a July 15 research note.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":805248454,"gmtCreate":1627886981878,"gmtModify":1703497214503,"author":{"id":"4087185180550510","authorId":"4087185180550510","authorIdStr":"4087185180550510","name":"Venus168","avatar":"https://community-static.tradeup.com/news/4896107829fe32fd3a83e066df1681a0","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4087185180550510"},"htmlText":"Buy buy buy[財迷]&nbsp;","listText":"Buy buy buy[財迷]&nbsp;","text":"Buy buy buy[財迷]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/805248454","repostId":1125617093,"repostType":4,"repost":{"id":"1125617093","pubTimestamp":1627875620,"share":"https://ttm.financial/m/news/1125617093?lang=&edition=fundamental","pubTime":"2021-08-02 11:40","market":"us","language":"en","title":"Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside","url":"https://stock-news.laohu8.com/highlight/detail?id=1125617093","media":"CNBC","summary":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health ","content":"<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs picks new stocks to buy from tech to health — some with over 100% upside\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 11:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"S":"SentinelOne, Inc","LULU":"lululemon athletica","AMAM":"Ambrx Biopharma Inc","LYEL":"Lyell Immunopharma, Inc.","TASK":"TaskUs Inc.","ZM":"Zoom","IS":"IronSource Ltd","02618":"京东物流","LYV":"Live Nation Entertainment","PVH":"PVH Corp","RL":"拉夫劳伦","02171":"科济药业-B","LEVI":"李维斯","IHRT":"iHeartMedia, Inc.","GS":"高盛"},"source_url":"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1125617093","content_text":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is buy-rated on about 45 — and some have a potential upside of over 100%.\nGoldman’s analysts initiated coverage on newly-listed companies that debuted on the stock market in the past few months, and also started providing research on some big-name apparel and media brands. Here’s a selection.\nHealth care\nU.S. insurance firm Bright Health Group, which operates insurance tech software as well as a platform connecting patients with health providers is buy-rated by the bank and raised nearly $1 billionin an initial public offering (IPO) in May. Goldman said it sees more than 100% upside to the share price from its current levels over 12 months, while trading at a “healthy” discount to other rapidly-growing insurers, according to a July 19 research note.\nGoldman also likes Ambrx Biopharma Inc, a cancer biotech firm, for its “pioneering research”, “unique and differentiated platform technology” and partnerships with pharmaceuticals companies such as Bristol Myers Squibb. The bank’s 12-month price target is $53, representing a 148.8% potential upside, the analysts said in a July 13 research note.\nHealth tech company Convey Holding Parent, Inc., which counts the likes of U.S. government insurance plan Medicare as a customer, is a buy for the bank. “We believe Convey differentiates itself from competitors as a provider of purpose-built healthcare IT software and services to government-sponsored health plans,” Goldman’s analysts wrote in a July 11 research note. The bank’s 12-month price target is $21, representing a potential 112.6% upside.\nLyell Immunopharma, Inc., which develops cancer therapies, is also buy-rated by the analysts. “We are encouraged by the preclinical data seen to-date and the experienced management team and note multiple programs are set to enter the clinic with first-in-human data next year,” Goldman’s analysts said in a July 12 research note. The bank’s 12-month price target is $30, representing a potential upside of 88.9%.\nOther new healthcare stocks Goldman picked include Chinese biotech firm CARSGEN-B, with a 12-month price target of 48.72 Hong Kong dollars ($6.25) — a potential upside of 62.7% — and Chinese firm AmoyDx, with a 12-month price target of 140 yuan renminbi ($21.52), a potential upside of 66.7%.\nTechnology\nDigital support company TaskUs Inc. is buy-rated, with Goldman giving it a 12-month price target of $61, a potential upside of 88.3%. The firm helps manage customer service for the likes of Zoom, which hired the company as the coronavirus pandemic struck in 2020. “We believe there is potential, given its historically high net retention rate, for it to grow above the consensus growth rates of its clients,” the bank’s analysts wrote in a July 6 note.\nGoldman gave IronSource Ltd, a “fast growing mobile ad platform at scaled margins,” a 12-month price target of $11, a potential upside of 23.7%. The company went public in Marchvia a special-purpose acquisition vehicle (SPAC)and the bank said it would benefit from growth in mobile apps and also liked its game development arm Sonic Publishing.\nSentinelOne, Inc, which debuted on the New York Stock Exchange in June and wasthe highest-valued cybersecurity IPO ever, is also buy-rated by the bank. Goldman described it as “a best of breed, founder-led XDR [extended detection and response] leader in one of the most attractive segments within Security Software,” in a July 25 research note. The bank gave the stock a 12-month price target of $57, a potential upside of 22.4%.\nGoldman also picked “leading” Chinese firm JD LOGISTICS— which became a separate entity to retail giant JD.com in 2017 — andlisted on the Hong Kong stock exchange in May. Goldman expects it to double its market share by 2025, growing via investments in supply chain technology, overseas expansion and additions to its air cargo network. The bank’s 12-month price target is 58.50 Hong Kong dollars, representing a potential upside of 38.3%.\nGoldman also likes Nasdaq-listed Turkish e-commerce giant Hepsiburada, with a 12-month price target of $25.90 — a potential upside of 95% — and Chinese electronics seller AiHuiShou, with a 12-month price target of $20.80, representing a potential upside of 48.1%.\nApparel\nGoldman started covering several apparel stocks this month and said the sector has “macro tailwinds from a strong consumer and supportive discretionary retail spend,” in a July 14 note to investors.\nAthleisure company Lululemon Athletica on Goldman’s conviction list, with the bank describing it as “a leader in driving online to offline consumer connection,” giving it a buy rating. The analysts likedits $500 million acquisition of fitness screen company Mirror, and gave the stock a $447 12-month target price, a potential upside of 21%.\nLuxury label Ralph Lauren has “potential upside” from digital sales via its own websites, according to Goldman, which is “upbeat” about the company’s turnaround, and it gave it a buy rating. The bank’s 12-month price target is $147, a potential upside of 28%.\nGoldman is also buy-rated on Calvin Klein owner PVH Corp, due to the company’s e-commerce focus, new management and pandemic restructuring, expecting the firm to provide “stronger” margins. The bank gave the stock a 12-month price target of $127, a potential upside of 21%.\nLevi Strauss & Co is a buy for the bank, which liked its “best-in-class heritage positioning.” “LEVI is emerging from the pandemic with a better-positioned US wholesale marketplace, a more agile organization with increased digital tools and a faster go-to-market,” Goldman said. Its 12-month price target is $36, a potential upside of 25%.\nMedia\nGoldman started covering concert promoter Live Nation Entertainment on July 15. “We initiate coverage on Live Nation (“LYV”) with a Buy rating and 12-month price target of $110, implying 35% total potential return,” the bank said. Goldman expects an uptick inlive events after the pandemicand sees growth opportunities in high-margin merchandise and VIP experiences.\nThe bank also likes audio firm iHeartMedia, Inc., calling it a “most undiscovered” stock, and “the leading multi-platform audio media company in the U.S.” “We initiate coverage on iHeartMedia (“IHRT”) with a Buy rating and a 12-month price target of $32, representing 25% total potential return,” the analysts said in a July 15 research note.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":805269494,"gmtCreate":1627884244918,"gmtModify":1703497166627,"author":{"id":"3581782846197879","authorId":"3581782846197879","authorIdStr":"3581782846197879","name":"Dreamchaser9","avatar":"https://static.tigerbbs.com/f4f8f000953179179078bdd5e6f748b6","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3581782846197879"},"htmlText":"Cool tips","listText":"Cool tips","text":"Cool tips","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/805269494","repostId":1125617093,"repostType":2,"repost":{"id":"1125617093","pubTimestamp":1627875620,"share":"https://ttm.financial/m/news/1125617093?lang=&edition=fundamental","pubTime":"2021-08-02 11:40","market":"us","language":"en","title":"Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside","url":"https://stock-news.laohu8.com/highlight/detail?id=1125617093","media":"CNBC","summary":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health ","content":"<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs picks new stocks to buy from tech to health — some with over 100% upside\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 11:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"S":"SentinelOne, Inc","LULU":"lululemon athletica","AMAM":"Ambrx Biopharma Inc","LYEL":"Lyell Immunopharma, Inc.","TASK":"TaskUs Inc.","ZM":"Zoom","IS":"IronSource Ltd","02618":"京东物流","LYV":"Live Nation Entertainment","PVH":"PVH Corp","RL":"拉夫劳伦","02171":"科济药业-B","LEVI":"李维斯","IHRT":"iHeartMedia, Inc.","GS":"高盛"},"source_url":"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1125617093","content_text":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is buy-rated on about 45 — and some have a potential upside of over 100%.\nGoldman’s analysts initiated coverage on newly-listed companies that debuted on the stock market in the past few months, and also started providing research on some big-name apparel and media brands. Here’s a selection.\nHealth care\nU.S. insurance firm Bright Health Group, which operates insurance tech software as well as a platform connecting patients with health providers is buy-rated by the bank and raised nearly $1 billionin an initial public offering (IPO) in May. Goldman said it sees more than 100% upside to the share price from its current levels over 12 months, while trading at a “healthy” discount to other rapidly-growing insurers, according to a July 19 research note.\nGoldman also likes Ambrx Biopharma Inc, a cancer biotech firm, for its “pioneering research”, “unique and differentiated platform technology” and partnerships with pharmaceuticals companies such as Bristol Myers Squibb. The bank’s 12-month price target is $53, representing a 148.8% potential upside, the analysts said in a July 13 research note.\nHealth tech company Convey Holding Parent, Inc., which counts the likes of U.S. government insurance plan Medicare as a customer, is a buy for the bank. “We believe Convey differentiates itself from competitors as a provider of purpose-built healthcare IT software and services to government-sponsored health plans,” Goldman’s analysts wrote in a July 11 research note. The bank’s 12-month price target is $21, representing a potential 112.6% upside.\nLyell Immunopharma, Inc., which develops cancer therapies, is also buy-rated by the analysts. “We are encouraged by the preclinical data seen to-date and the experienced management team and note multiple programs are set to enter the clinic with first-in-human data next year,” Goldman’s analysts said in a July 12 research note. The bank’s 12-month price target is $30, representing a potential upside of 88.9%.\nOther new healthcare stocks Goldman picked include Chinese biotech firm CARSGEN-B, with a 12-month price target of 48.72 Hong Kong dollars ($6.25) — a potential upside of 62.7% — and Chinese firm AmoyDx, with a 12-month price target of 140 yuan renminbi ($21.52), a potential upside of 66.7%.\nTechnology\nDigital support company TaskUs Inc. is buy-rated, with Goldman giving it a 12-month price target of $61, a potential upside of 88.3%. The firm helps manage customer service for the likes of Zoom, which hired the company as the coronavirus pandemic struck in 2020. “We believe there is potential, given its historically high net retention rate, for it to grow above the consensus growth rates of its clients,” the bank’s analysts wrote in a July 6 note.\nGoldman gave IronSource Ltd, a “fast growing mobile ad platform at scaled margins,” a 12-month price target of $11, a potential upside of 23.7%. The company went public in Marchvia a special-purpose acquisition vehicle (SPAC)and the bank said it would benefit from growth in mobile apps and also liked its game development arm Sonic Publishing.\nSentinelOne, Inc, which debuted on the New York Stock Exchange in June and wasthe highest-valued cybersecurity IPO ever, is also buy-rated by the bank. Goldman described it as “a best of breed, founder-led XDR [extended detection and response] leader in one of the most attractive segments within Security Software,” in a July 25 research note. The bank gave the stock a 12-month price target of $57, a potential upside of 22.4%.\nGoldman also picked “leading” Chinese firm JD LOGISTICS— which became a separate entity to retail giant JD.com in 2017 — andlisted on the Hong Kong stock exchange in May. Goldman expects it to double its market share by 2025, growing via investments in supply chain technology, overseas expansion and additions to its air cargo network. The bank’s 12-month price target is 58.50 Hong Kong dollars, representing a potential upside of 38.3%.\nGoldman also likes Nasdaq-listed Turkish e-commerce giant Hepsiburada, with a 12-month price target of $25.90 — a potential upside of 95% — and Chinese electronics seller AiHuiShou, with a 12-month price target of $20.80, representing a potential upside of 48.1%.\nApparel\nGoldman started covering several apparel stocks this month and said the sector has “macro tailwinds from a strong consumer and supportive discretionary retail spend,” in a July 14 note to investors.\nAthleisure company Lululemon Athletica on Goldman’s conviction list, with the bank describing it as “a leader in driving online to offline consumer connection,” giving it a buy rating. The analysts likedits $500 million acquisition of fitness screen company Mirror, and gave the stock a $447 12-month target price, a potential upside of 21%.\nLuxury label Ralph Lauren has “potential upside” from digital sales via its own websites, according to Goldman, which is “upbeat” about the company’s turnaround, and it gave it a buy rating. The bank’s 12-month price target is $147, a potential upside of 28%.\nGoldman is also buy-rated on Calvin Klein owner PVH Corp, due to the company’s e-commerce focus, new management and pandemic restructuring, expecting the firm to provide “stronger” margins. The bank gave the stock a 12-month price target of $127, a potential upside of 21%.\nLevi Strauss & Co is a buy for the bank, which liked its “best-in-class heritage positioning.” “LEVI is emerging from the pandemic with a better-positioned US wholesale marketplace, a more agile organization with increased digital tools and a faster go-to-market,” Goldman said. Its 12-month price target is $36, a potential upside of 25%.\nMedia\nGoldman started covering concert promoter Live Nation Entertainment on July 15. “We initiate coverage on Live Nation (“LYV”) with a Buy rating and 12-month price target of $110, implying 35% total potential return,” the bank said. Goldman expects an uptick inlive events after the pandemicand sees growth opportunities in high-margin merchandise and VIP experiences.\nThe bank also likes audio firm iHeartMedia, Inc., calling it a “most undiscovered” stock, and “the leading multi-platform audio media company in the U.S.” “We initiate coverage on iHeartMedia (“IHRT”) with a Buy rating and a 12-month price target of $32, representing 25% total potential return,” the analysts said in a July 15 research note.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":805239363,"gmtCreate":1627882004252,"gmtModify":1703497121364,"author":{"id":"4087932884013320","authorId":"4087932884013320","authorIdStr":"4087932884013320","name":"BlueDragon","avatar":"https://static.tigerbbs.com/431c326e19a16844e147d10866565f27","vip":1,"crmLevel":2,"crmLevelSwitch":1,"idStr":"4087932884013320"},"htmlText":"Nice and like","listText":"Nice and like","text":"Nice and like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/805239363","repostId":1125617093,"repostType":4,"repost":{"id":"1125617093","pubTimestamp":1627875620,"share":"https://ttm.financial/m/news/1125617093?lang=&edition=fundamental","pubTime":"2021-08-02 11:40","market":"us","language":"en","title":"Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside","url":"https://stock-news.laohu8.com/highlight/detail?id=1125617093","media":"CNBC","summary":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health ","content":"<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs picks new stocks to buy from tech to health — some with over 100% upside\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 11:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"S":"SentinelOne, Inc","LULU":"lululemon athletica","AMAM":"Ambrx Biopharma Inc","LYEL":"Lyell Immunopharma, Inc.","TASK":"TaskUs Inc.","ZM":"Zoom","IS":"IronSource Ltd","02618":"京东物流","LYV":"Live Nation Entertainment","PVH":"PVH Corp","RL":"拉夫劳伦","02171":"科济药业-B","LEVI":"李维斯","IHRT":"iHeartMedia, Inc.","GS":"高盛"},"source_url":"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1125617093","content_text":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is buy-rated on about 45 — and some have a potential upside of over 100%.\nGoldman’s analysts initiated coverage on newly-listed companies that debuted on the stock market in the past few months, and also started providing research on some big-name apparel and media brands. Here’s a selection.\nHealth care\nU.S. insurance firm Bright Health Group, which operates insurance tech software as well as a platform connecting patients with health providers is buy-rated by the bank and raised nearly $1 billionin an initial public offering (IPO) in May. Goldman said it sees more than 100% upside to the share price from its current levels over 12 months, while trading at a “healthy” discount to other rapidly-growing insurers, according to a July 19 research note.\nGoldman also likes Ambrx Biopharma Inc, a cancer biotech firm, for its “pioneering research”, “unique and differentiated platform technology” and partnerships with pharmaceuticals companies such as Bristol Myers Squibb. The bank’s 12-month price target is $53, representing a 148.8% potential upside, the analysts said in a July 13 research note.\nHealth tech company Convey Holding Parent, Inc., which counts the likes of U.S. government insurance plan Medicare as a customer, is a buy for the bank. “We believe Convey differentiates itself from competitors as a provider of purpose-built healthcare IT software and services to government-sponsored health plans,” Goldman’s analysts wrote in a July 11 research note. The bank’s 12-month price target is $21, representing a potential 112.6% upside.\nLyell Immunopharma, Inc., which develops cancer therapies, is also buy-rated by the analysts. “We are encouraged by the preclinical data seen to-date and the experienced management team and note multiple programs are set to enter the clinic with first-in-human data next year,” Goldman’s analysts said in a July 12 research note. The bank’s 12-month price target is $30, representing a potential upside of 88.9%.\nOther new healthcare stocks Goldman picked include Chinese biotech firm CARSGEN-B, with a 12-month price target of 48.72 Hong Kong dollars ($6.25) — a potential upside of 62.7% — and Chinese firm AmoyDx, with a 12-month price target of 140 yuan renminbi ($21.52), a potential upside of 66.7%.\nTechnology\nDigital support company TaskUs Inc. is buy-rated, with Goldman giving it a 12-month price target of $61, a potential upside of 88.3%. The firm helps manage customer service for the likes of Zoom, which hired the company as the coronavirus pandemic struck in 2020. “We believe there is potential, given its historically high net retention rate, for it to grow above the consensus growth rates of its clients,” the bank’s analysts wrote in a July 6 note.\nGoldman gave IronSource Ltd, a “fast growing mobile ad platform at scaled margins,” a 12-month price target of $11, a potential upside of 23.7%. The company went public in Marchvia a special-purpose acquisition vehicle (SPAC)and the bank said it would benefit from growth in mobile apps and also liked its game development arm Sonic Publishing.\nSentinelOne, Inc, which debuted on the New York Stock Exchange in June and wasthe highest-valued cybersecurity IPO ever, is also buy-rated by the bank. Goldman described it as “a best of breed, founder-led XDR [extended detection and response] leader in one of the most attractive segments within Security Software,” in a July 25 research note. The bank gave the stock a 12-month price target of $57, a potential upside of 22.4%.\nGoldman also picked “leading” Chinese firm JD LOGISTICS— which became a separate entity to retail giant JD.com in 2017 — andlisted on the Hong Kong stock exchange in May. Goldman expects it to double its market share by 2025, growing via investments in supply chain technology, overseas expansion and additions to its air cargo network. The bank’s 12-month price target is 58.50 Hong Kong dollars, representing a potential upside of 38.3%.\nGoldman also likes Nasdaq-listed Turkish e-commerce giant Hepsiburada, with a 12-month price target of $25.90 — a potential upside of 95% — and Chinese electronics seller AiHuiShou, with a 12-month price target of $20.80, representing a potential upside of 48.1%.\nApparel\nGoldman started covering several apparel stocks this month and said the sector has “macro tailwinds from a strong consumer and supportive discretionary retail spend,” in a July 14 note to investors.\nAthleisure company Lululemon Athletica on Goldman’s conviction list, with the bank describing it as “a leader in driving online to offline consumer connection,” giving it a buy rating. The analysts likedits $500 million acquisition of fitness screen company Mirror, and gave the stock a $447 12-month target price, a potential upside of 21%.\nLuxury label Ralph Lauren has “potential upside” from digital sales via its own websites, according to Goldman, which is “upbeat” about the company’s turnaround, and it gave it a buy rating. The bank’s 12-month price target is $147, a potential upside of 28%.\nGoldman is also buy-rated on Calvin Klein owner PVH Corp, due to the company’s e-commerce focus, new management and pandemic restructuring, expecting the firm to provide “stronger” margins. The bank gave the stock a 12-month price target of $127, a potential upside of 21%.\nLevi Strauss & Co is a buy for the bank, which liked its “best-in-class heritage positioning.” “LEVI is emerging from the pandemic with a better-positioned US wholesale marketplace, a more agile organization with increased digital tools and a faster go-to-market,” Goldman said. Its 12-month price target is $36, a potential upside of 25%.\nMedia\nGoldman started covering concert promoter Live Nation Entertainment on July 15. “We initiate coverage on Live Nation (“LYV”) with a Buy rating and 12-month price target of $110, implying 35% total potential return,” the bank said. Goldman expects an uptick inlive events after the pandemicand sees growth opportunities in high-margin merchandise and VIP experiences.\nThe bank also likes audio firm iHeartMedia, Inc., calling it a “most undiscovered” stock, and “the leading multi-platform audio media company in the U.S.” “We initiate coverage on iHeartMedia (“IHRT”) with a Buy rating and a 12-month price target of $32, representing 25% total potential return,” the analysts said in a July 15 research note.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":805206375,"gmtCreate":1627880574097,"gmtModify":1703497098664,"author":{"id":"3571345352614779","authorId":"3571345352614779","authorIdStr":"3571345352614779","name":"xiaobaii","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3571345352614779"},"htmlText":"like &amp; comment please, thank you very much&nbsp;","listText":"like &amp; comment please, thank you very much&nbsp;","text":"like & comment please, thank you very much","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/805206375","repostId":1125617093,"repostType":4,"repost":{"id":"1125617093","pubTimestamp":1627875620,"share":"https://ttm.financial/m/news/1125617093?lang=&edition=fundamental","pubTime":"2021-08-02 11:40","market":"us","language":"en","title":"Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside","url":"https://stock-news.laohu8.com/highlight/detail?id=1125617093","media":"CNBC","summary":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health ","content":"<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs picks new stocks to buy from tech to health — some with over 100% upside\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 11:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"S":"SentinelOne, Inc","LULU":"lululemon athletica","AMAM":"Ambrx Biopharma Inc","LYEL":"Lyell Immunopharma, Inc.","TASK":"TaskUs Inc.","ZM":"Zoom","IS":"IronSource Ltd","02618":"京东物流","LYV":"Live Nation Entertainment","PVH":"PVH Corp","RL":"拉夫劳伦","02171":"科济药业-B","LEVI":"李维斯","IHRT":"iHeartMedia, Inc.","GS":"高盛"},"source_url":"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1125617093","content_text":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is buy-rated on about 45 — and some have a potential upside of over 100%.\nGoldman’s analysts initiated coverage on newly-listed companies that debuted on the stock market in the past few months, and also started providing research on some big-name apparel and media brands. Here’s a selection.\nHealth care\nU.S. insurance firm Bright Health Group, which operates insurance tech software as well as a platform connecting patients with health providers is buy-rated by the bank and raised nearly $1 billionin an initial public offering (IPO) in May. Goldman said it sees more than 100% upside to the share price from its current levels over 12 months, while trading at a “healthy” discount to other rapidly-growing insurers, according to a July 19 research note.\nGoldman also likes Ambrx Biopharma Inc, a cancer biotech firm, for its “pioneering research”, “unique and differentiated platform technology” and partnerships with pharmaceuticals companies such as Bristol Myers Squibb. The bank’s 12-month price target is $53, representing a 148.8% potential upside, the analysts said in a July 13 research note.\nHealth tech company Convey Holding Parent, Inc., which counts the likes of U.S. government insurance plan Medicare as a customer, is a buy for the bank. “We believe Convey differentiates itself from competitors as a provider of purpose-built healthcare IT software and services to government-sponsored health plans,” Goldman’s analysts wrote in a July 11 research note. The bank’s 12-month price target is $21, representing a potential 112.6% upside.\nLyell Immunopharma, Inc., which develops cancer therapies, is also buy-rated by the analysts. “We are encouraged by the preclinical data seen to-date and the experienced management team and note multiple programs are set to enter the clinic with first-in-human data next year,” Goldman’s analysts said in a July 12 research note. The bank’s 12-month price target is $30, representing a potential upside of 88.9%.\nOther new healthcare stocks Goldman picked include Chinese biotech firm CARSGEN-B, with a 12-month price target of 48.72 Hong Kong dollars ($6.25) — a potential upside of 62.7% — and Chinese firm AmoyDx, with a 12-month price target of 140 yuan renminbi ($21.52), a potential upside of 66.7%.\nTechnology\nDigital support company TaskUs Inc. is buy-rated, with Goldman giving it a 12-month price target of $61, a potential upside of 88.3%. The firm helps manage customer service for the likes of Zoom, which hired the company as the coronavirus pandemic struck in 2020. “We believe there is potential, given its historically high net retention rate, for it to grow above the consensus growth rates of its clients,” the bank’s analysts wrote in a July 6 note.\nGoldman gave IronSource Ltd, a “fast growing mobile ad platform at scaled margins,” a 12-month price target of $11, a potential upside of 23.7%. The company went public in Marchvia a special-purpose acquisition vehicle (SPAC)and the bank said it would benefit from growth in mobile apps and also liked its game development arm Sonic Publishing.\nSentinelOne, Inc, which debuted on the New York Stock Exchange in June and wasthe highest-valued cybersecurity IPO ever, is also buy-rated by the bank. Goldman described it as “a best of breed, founder-led XDR [extended detection and response] leader in one of the most attractive segments within Security Software,” in a July 25 research note. The bank gave the stock a 12-month price target of $57, a potential upside of 22.4%.\nGoldman also picked “leading” Chinese firm JD LOGISTICS— which became a separate entity to retail giant JD.com in 2017 — andlisted on the Hong Kong stock exchange in May. Goldman expects it to double its market share by 2025, growing via investments in supply chain technology, overseas expansion and additions to its air cargo network. The bank’s 12-month price target is 58.50 Hong Kong dollars, representing a potential upside of 38.3%.\nGoldman also likes Nasdaq-listed Turkish e-commerce giant Hepsiburada, with a 12-month price target of $25.90 — a potential upside of 95% — and Chinese electronics seller AiHuiShou, with a 12-month price target of $20.80, representing a potential upside of 48.1%.\nApparel\nGoldman started covering several apparel stocks this month and said the sector has “macro tailwinds from a strong consumer and supportive discretionary retail spend,” in a July 14 note to investors.\nAthleisure company Lululemon Athletica on Goldman’s conviction list, with the bank describing it as “a leader in driving online to offline consumer connection,” giving it a buy rating. The analysts likedits $500 million acquisition of fitness screen company Mirror, and gave the stock a $447 12-month target price, a potential upside of 21%.\nLuxury label Ralph Lauren has “potential upside” from digital sales via its own websites, according to Goldman, which is “upbeat” about the company’s turnaround, and it gave it a buy rating. The bank’s 12-month price target is $147, a potential upside of 28%.\nGoldman is also buy-rated on Calvin Klein owner PVH Corp, due to the company’s e-commerce focus, new management and pandemic restructuring, expecting the firm to provide “stronger” margins. The bank gave the stock a 12-month price target of $127, a potential upside of 21%.\nLevi Strauss & Co is a buy for the bank, which liked its “best-in-class heritage positioning.” “LEVI is emerging from the pandemic with a better-positioned US wholesale marketplace, a more agile organization with increased digital tools and a faster go-to-market,” Goldman said. Its 12-month price target is $36, a potential upside of 25%.\nMedia\nGoldman started covering concert promoter Live Nation Entertainment on July 15. “We initiate coverage on Live Nation (“LYV”) with a Buy rating and 12-month price target of $110, implying 35% total potential return,” the bank said. Goldman expects an uptick inlive events after the pandemicand sees growth opportunities in high-margin merchandise and VIP experiences.\nThe bank also likes audio firm iHeartMedia, Inc., calling it a “most undiscovered” stock, and “the leading multi-platform audio media company in the U.S.” “We initiate coverage on iHeartMedia (“IHRT”) with a Buy rating and a 12-month price target of $32, representing 25% total potential return,” the analysts said in a July 15 research note.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5400796,"gmtCreate":1627884259678,"gmtModify":1663231812057,"authorId":3581782846197879,"author":{"id":3581782846197879,"authorId":3581782846197879,"name":"Dreamchaser9","avatar":"https://static.tigerbbs.com/f4f8f000953179179078bdd5e6f748b6","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805206375,"type":1,"supId":0,"prevId":0,"content":"Done","text":"Done","html":"Done"}],"langContent":"EN"},{"id":805673009,"gmtCreate":1627879746701,"gmtModify":1703497078305,"author":{"id":"3554967010672825","authorId":"3554967010672825","authorIdStr":"3554967010672825","name":"Jerronlyq","avatar":"https://static.tigerbbs.com/33bbb4d2763a11af2f57a00cb54afc91","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3554967010672825"},"htmlText":"Niceee","listText":"Niceee","text":"Niceee","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/805673009","repostId":1125617093,"repostType":4,"repost":{"id":"1125617093","pubTimestamp":1627875620,"share":"https://ttm.financial/m/news/1125617093?lang=&edition=fundamental","pubTime":"2021-08-02 11:40","market":"us","language":"en","title":"Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside","url":"https://stock-news.laohu8.com/highlight/detail?id=1125617093","media":"CNBC","summary":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health ","content":"<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs picks new stocks to buy from tech to health — some with over 100% upside\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 11:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"S":"SentinelOne, Inc","LULU":"lululemon athletica","AMAM":"Ambrx Biopharma Inc","LYEL":"Lyell Immunopharma, Inc.","TASK":"TaskUs Inc.","ZM":"Zoom","IS":"IronSource Ltd","02618":"京东物流","LYV":"Live Nation Entertainment","PVH":"PVH Corp","RL":"拉夫劳伦","02171":"科济药业-B","LEVI":"李维斯","IHRT":"iHeartMedia, Inc.","GS":"高盛"},"source_url":"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1125617093","content_text":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is buy-rated on about 45 — and some have a potential upside of over 100%.\nGoldman’s analysts initiated coverage on newly-listed companies that debuted on the stock market in the past few months, and also started providing research on some big-name apparel and media brands. Here’s a selection.\nHealth care\nU.S. insurance firm Bright Health Group, which operates insurance tech software as well as a platform connecting patients with health providers is buy-rated by the bank and raised nearly $1 billionin an initial public offering (IPO) in May. Goldman said it sees more than 100% upside to the share price from its current levels over 12 months, while trading at a “healthy” discount to other rapidly-growing insurers, according to a July 19 research note.\nGoldman also likes Ambrx Biopharma Inc, a cancer biotech firm, for its “pioneering research”, “unique and differentiated platform technology” and partnerships with pharmaceuticals companies such as Bristol Myers Squibb. The bank’s 12-month price target is $53, representing a 148.8% potential upside, the analysts said in a July 13 research note.\nHealth tech company Convey Holding Parent, Inc., which counts the likes of U.S. government insurance plan Medicare as a customer, is a buy for the bank. “We believe Convey differentiates itself from competitors as a provider of purpose-built healthcare IT software and services to government-sponsored health plans,” Goldman’s analysts wrote in a July 11 research note. The bank’s 12-month price target is $21, representing a potential 112.6% upside.\nLyell Immunopharma, Inc., which develops cancer therapies, is also buy-rated by the analysts. “We are encouraged by the preclinical data seen to-date and the experienced management team and note multiple programs are set to enter the clinic with first-in-human data next year,” Goldman’s analysts said in a July 12 research note. The bank’s 12-month price target is $30, representing a potential upside of 88.9%.\nOther new healthcare stocks Goldman picked include Chinese biotech firm CARSGEN-B, with a 12-month price target of 48.72 Hong Kong dollars ($6.25) — a potential upside of 62.7% — and Chinese firm AmoyDx, with a 12-month price target of 140 yuan renminbi ($21.52), a potential upside of 66.7%.\nTechnology\nDigital support company TaskUs Inc. is buy-rated, with Goldman giving it a 12-month price target of $61, a potential upside of 88.3%. The firm helps manage customer service for the likes of Zoom, which hired the company as the coronavirus pandemic struck in 2020. “We believe there is potential, given its historically high net retention rate, for it to grow above the consensus growth rates of its clients,” the bank’s analysts wrote in a July 6 note.\nGoldman gave IronSource Ltd, a “fast growing mobile ad platform at scaled margins,” a 12-month price target of $11, a potential upside of 23.7%. The company went public in Marchvia a special-purpose acquisition vehicle (SPAC)and the bank said it would benefit from growth in mobile apps and also liked its game development arm Sonic Publishing.\nSentinelOne, Inc, which debuted on the New York Stock Exchange in June and wasthe highest-valued cybersecurity IPO ever, is also buy-rated by the bank. Goldman described it as “a best of breed, founder-led XDR [extended detection and response] leader in one of the most attractive segments within Security Software,” in a July 25 research note. The bank gave the stock a 12-month price target of $57, a potential upside of 22.4%.\nGoldman also picked “leading” Chinese firm JD LOGISTICS— which became a separate entity to retail giant JD.com in 2017 — andlisted on the Hong Kong stock exchange in May. Goldman expects it to double its market share by 2025, growing via investments in supply chain technology, overseas expansion and additions to its air cargo network. The bank’s 12-month price target is 58.50 Hong Kong dollars, representing a potential upside of 38.3%.\nGoldman also likes Nasdaq-listed Turkish e-commerce giant Hepsiburada, with a 12-month price target of $25.90 — a potential upside of 95% — and Chinese electronics seller AiHuiShou, with a 12-month price target of $20.80, representing a potential upside of 48.1%.\nApparel\nGoldman started covering several apparel stocks this month and said the sector has “macro tailwinds from a strong consumer and supportive discretionary retail spend,” in a July 14 note to investors.\nAthleisure company Lululemon Athletica on Goldman’s conviction list, with the bank describing it as “a leader in driving online to offline consumer connection,” giving it a buy rating. The analysts likedits $500 million acquisition of fitness screen company Mirror, and gave the stock a $447 12-month target price, a potential upside of 21%.\nLuxury label Ralph Lauren has “potential upside” from digital sales via its own websites, according to Goldman, which is “upbeat” about the company’s turnaround, and it gave it a buy rating. The bank’s 12-month price target is $147, a potential upside of 28%.\nGoldman is also buy-rated on Calvin Klein owner PVH Corp, due to the company’s e-commerce focus, new management and pandemic restructuring, expecting the firm to provide “stronger” margins. The bank gave the stock a 12-month price target of $127, a potential upside of 21%.\nLevi Strauss & Co is a buy for the bank, which liked its “best-in-class heritage positioning.” “LEVI is emerging from the pandemic with a better-positioned US wholesale marketplace, a more agile organization with increased digital tools and a faster go-to-market,” Goldman said. Its 12-month price target is $36, a potential upside of 25%.\nMedia\nGoldman started covering concert promoter Live Nation Entertainment on July 15. “We initiate coverage on Live Nation (“LYV”) with a Buy rating and 12-month price target of $110, implying 35% total potential return,” the bank said. Goldman expects an uptick inlive events after the pandemicand sees growth opportunities in high-margin merchandise and VIP experiences.\nThe bank also likes audio firm iHeartMedia, Inc., calling it a “most undiscovered” stock, and “the leading multi-platform audio media company in the U.S.” “We initiate coverage on iHeartMedia (“IHRT”) with a Buy rating and a 12-month price target of $32, representing 25% total potential return,” the analysts said in a July 15 research note.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5400447,"gmtCreate":1627880583991,"gmtModify":1663231810739,"authorId":3571345352614779,"author":{"id":3571345352614779,"authorId":3571345352614779,"name":"xiaobaii","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805673009,"type":1,"supId":0,"prevId":0,"content":"like &amp; comment please, thank you very much ","text":"like &amp; comment please, thank you very much ","html":"like &amp; comment please, thank you very much "},{"id":5400373,"gmtCreate":1627879981868,"gmtModify":1663231810245,"authorId":4087368751013300,"author":{"id":4087368751013300,"authorId":4087368751013300,"name":"TraderBoss28","avatar":"https://static.tigerbbs.com/4b15aebf8b95503b8c3ca1d2b37137cb","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805673009,"type":1,"supId":0,"prevId":0,"content":"Noted","text":"Noted","html":"Noted"}],"langContent":"EN"},{"id":805670014,"gmtCreate":1627879616738,"gmtModify":1703497075166,"author":{"id":"3572945845916163","authorId":"3572945845916163","authorIdStr":"3572945845916163","name":"NareshwG","avatar":"https://static.tigerbbs.com/0d6dc06165c1a0cc4f1a8169ea48573d","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3572945845916163"},"htmlText":"They need to promote in order to earn commission. So, we have to be careful and take the ideas with a pinch of salt..","listText":"They need to promote in order to earn commission. So, we have to be careful and take the ideas with a pinch of salt..","text":"They need to promote in order to earn commission. So, we have to be careful and take the ideas with a pinch of salt..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/805670014","repostId":1125617093,"repostType":4,"repost":{"id":"1125617093","pubTimestamp":1627875620,"share":"https://ttm.financial/m/news/1125617093?lang=&edition=fundamental","pubTime":"2021-08-02 11:40","market":"us","language":"en","title":"Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside","url":"https://stock-news.laohu8.com/highlight/detail?id=1125617093","media":"CNBC","summary":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health ","content":"<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs picks new stocks to buy from tech to health — some with over 100% upside\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 11:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"S":"SentinelOne, Inc","LULU":"lululemon athletica","AMAM":"Ambrx Biopharma Inc","LYEL":"Lyell Immunopharma, Inc.","TASK":"TaskUs Inc.","ZM":"Zoom","IS":"IronSource Ltd","02618":"京东物流","LYV":"Live Nation Entertainment","PVH":"PVH Corp","RL":"拉夫劳伦","02171":"科济药业-B","LEVI":"李维斯","IHRT":"iHeartMedia, Inc.","GS":"高盛"},"source_url":"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1125617093","content_text":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is buy-rated on about 45 — and some have a potential upside of over 100%.\nGoldman’s analysts initiated coverage on newly-listed companies that debuted on the stock market in the past few months, and also started providing research on some big-name apparel and media brands. Here’s a selection.\nHealth care\nU.S. insurance firm Bright Health Group, which operates insurance tech software as well as a platform connecting patients with health providers is buy-rated by the bank and raised nearly $1 billionin an initial public offering (IPO) in May. Goldman said it sees more than 100% upside to the share price from its current levels over 12 months, while trading at a “healthy” discount to other rapidly-growing insurers, according to a July 19 research note.\nGoldman also likes Ambrx Biopharma Inc, a cancer biotech firm, for its “pioneering research”, “unique and differentiated platform technology” and partnerships with pharmaceuticals companies such as Bristol Myers Squibb. The bank’s 12-month price target is $53, representing a 148.8% potential upside, the analysts said in a July 13 research note.\nHealth tech company Convey Holding Parent, Inc., which counts the likes of U.S. government insurance plan Medicare as a customer, is a buy for the bank. “We believe Convey differentiates itself from competitors as a provider of purpose-built healthcare IT software and services to government-sponsored health plans,” Goldman’s analysts wrote in a July 11 research note. The bank’s 12-month price target is $21, representing a potential 112.6% upside.\nLyell Immunopharma, Inc., which develops cancer therapies, is also buy-rated by the analysts. “We are encouraged by the preclinical data seen to-date and the experienced management team and note multiple programs are set to enter the clinic with first-in-human data next year,” Goldman’s analysts said in a July 12 research note. The bank’s 12-month price target is $30, representing a potential upside of 88.9%.\nOther new healthcare stocks Goldman picked include Chinese biotech firm CARSGEN-B, with a 12-month price target of 48.72 Hong Kong dollars ($6.25) — a potential upside of 62.7% — and Chinese firm AmoyDx, with a 12-month price target of 140 yuan renminbi ($21.52), a potential upside of 66.7%.\nTechnology\nDigital support company TaskUs Inc. is buy-rated, with Goldman giving it a 12-month price target of $61, a potential upside of 88.3%. The firm helps manage customer service for the likes of Zoom, which hired the company as the coronavirus pandemic struck in 2020. “We believe there is potential, given its historically high net retention rate, for it to grow above the consensus growth rates of its clients,” the bank’s analysts wrote in a July 6 note.\nGoldman gave IronSource Ltd, a “fast growing mobile ad platform at scaled margins,” a 12-month price target of $11, a potential upside of 23.7%. The company went public in Marchvia a special-purpose acquisition vehicle (SPAC)and the bank said it would benefit from growth in mobile apps and also liked its game development arm Sonic Publishing.\nSentinelOne, Inc, which debuted on the New York Stock Exchange in June and wasthe highest-valued cybersecurity IPO ever, is also buy-rated by the bank. Goldman described it as “a best of breed, founder-led XDR [extended detection and response] leader in one of the most attractive segments within Security Software,” in a July 25 research note. The bank gave the stock a 12-month price target of $57, a potential upside of 22.4%.\nGoldman also picked “leading” Chinese firm JD LOGISTICS— which became a separate entity to retail giant JD.com in 2017 — andlisted on the Hong Kong stock exchange in May. Goldman expects it to double its market share by 2025, growing via investments in supply chain technology, overseas expansion and additions to its air cargo network. The bank’s 12-month price target is 58.50 Hong Kong dollars, representing a potential upside of 38.3%.\nGoldman also likes Nasdaq-listed Turkish e-commerce giant Hepsiburada, with a 12-month price target of $25.90 — a potential upside of 95% — and Chinese electronics seller AiHuiShou, with a 12-month price target of $20.80, representing a potential upside of 48.1%.\nApparel\nGoldman started covering several apparel stocks this month and said the sector has “macro tailwinds from a strong consumer and supportive discretionary retail spend,” in a July 14 note to investors.\nAthleisure company Lululemon Athletica on Goldman’s conviction list, with the bank describing it as “a leader in driving online to offline consumer connection,” giving it a buy rating. The analysts likedits $500 million acquisition of fitness screen company Mirror, and gave the stock a $447 12-month target price, a potential upside of 21%.\nLuxury label Ralph Lauren has “potential upside” from digital sales via its own websites, according to Goldman, which is “upbeat” about the company’s turnaround, and it gave it a buy rating. The bank’s 12-month price target is $147, a potential upside of 28%.\nGoldman is also buy-rated on Calvin Klein owner PVH Corp, due to the company’s e-commerce focus, new management and pandemic restructuring, expecting the firm to provide “stronger” margins. The bank gave the stock a 12-month price target of $127, a potential upside of 21%.\nLevi Strauss & Co is a buy for the bank, which liked its “best-in-class heritage positioning.” “LEVI is emerging from the pandemic with a better-positioned US wholesale marketplace, a more agile organization with increased digital tools and a faster go-to-market,” Goldman said. Its 12-month price target is $36, a potential upside of 25%.\nMedia\nGoldman started covering concert promoter Live Nation Entertainment on July 15. “We initiate coverage on Live Nation (“LYV”) with a Buy rating and 12-month price target of $110, implying 35% total potential return,” the bank said. Goldman expects an uptick inlive events after the pandemicand sees growth opportunities in high-margin merchandise and VIP experiences.\nThe bank also likes audio firm iHeartMedia, Inc., calling it a “most undiscovered” stock, and “the leading multi-platform audio media company in the U.S.” “We initiate coverage on iHeartMedia (“IHRT”) with a Buy rating and a 12-month price target of $32, representing 25% total potential return,” the analysts said in a July 15 research note.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5403557,"gmtCreate":1627908888686,"gmtModify":1663231824532,"authorId":3572945845916163,"author":{"id":3572945845916163,"authorId":3572945845916163,"name":"NareshwG","avatar":"https://static.tigerbbs.com/0d6dc06165c1a0cc4f1a8169ea48573d","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805670014,"type":1,"supId":5400449,"prevId":0,"content":"All the best to you =)","text":"All the best to you =)","html":"All the best to you =)"},{"id":5400449,"gmtCreate":1627880592734,"gmtModify":1663231810837,"authorId":3571345352614779,"author":{"id":3571345352614779,"authorId":3571345352614779,"name":"xiaobaii","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805670014,"type":1,"supId":0,"prevId":0,"content":"like &amp; comment please, thank you very much ","text":"like &amp; comment please, thank you very much ","html":"like &amp; comment please, thank you very much "},{"id":5400798,"gmtCreate":1627884288691,"gmtModify":1631896035913,"authorId":3561472805649521,"author":{"id":3561472805649521,"authorId":3561472805649521,"name":"hlw8888","avatar":"https://static.tigerbbs.com/2ac2fb959ae09e12e50b3a31148fe95a","vip":1,"crmLevel":3,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805670014,"type":1,"supId":0,"prevId":0,"content":"that's true... wallet limited.","text":"that's true... wallet limited.","html":"that's true... wallet limited."}],"langContent":"EN"},{"id":805646470,"gmtCreate":1627879311590,"gmtModify":1703497068378,"author":{"id":"3564648657215594","authorId":"3564648657215594","authorIdStr":"3564648657215594","name":"Bptan1973","avatar":"https://static.tigerbbs.com/3bc9afb30415a151838a752cc38621fc","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3564648657215594"},"htmlText":"Jd my favorite stock&nbsp;","listText":"Jd my favorite stock&nbsp;","text":"Jd my favorite stock","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/805646470","repostId":1125617093,"repostType":4,"repost":{"id":"1125617093","pubTimestamp":1627875620,"share":"https://ttm.financial/m/news/1125617093?lang=&edition=fundamental","pubTime":"2021-08-02 11:40","market":"us","language":"en","title":"Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside","url":"https://stock-news.laohu8.com/highlight/detail?id=1125617093","media":"CNBC","summary":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health ","content":"<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs picks new stocks to buy from tech to health — some with over 100% upside\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 11:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"S":"SentinelOne, Inc","LULU":"lululemon athletica","AMAM":"Ambrx Biopharma Inc","LYEL":"Lyell Immunopharma, Inc.","TASK":"TaskUs Inc.","ZM":"Zoom","IS":"IronSource Ltd","02618":"京东物流","LYV":"Live Nation Entertainment","PVH":"PVH Corp","RL":"拉夫劳伦","02171":"科济药业-B","LEVI":"李维斯","IHRT":"iHeartMedia, Inc.","GS":"高盛"},"source_url":"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1125617093","content_text":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is buy-rated on about 45 — and some have a potential upside of over 100%.\nGoldman’s analysts initiated coverage on newly-listed companies that debuted on the stock market in the past few months, and also started providing research on some big-name apparel and media brands. Here’s a selection.\nHealth care\nU.S. insurance firm Bright Health Group, which operates insurance tech software as well as a platform connecting patients with health providers is buy-rated by the bank and raised nearly $1 billionin an initial public offering (IPO) in May. Goldman said it sees more than 100% upside to the share price from its current levels over 12 months, while trading at a “healthy” discount to other rapidly-growing insurers, according to a July 19 research note.\nGoldman also likes Ambrx Biopharma Inc, a cancer biotech firm, for its “pioneering research”, “unique and differentiated platform technology” and partnerships with pharmaceuticals companies such as Bristol Myers Squibb. The bank’s 12-month price target is $53, representing a 148.8% potential upside, the analysts said in a July 13 research note.\nHealth tech company Convey Holding Parent, Inc., which counts the likes of U.S. government insurance plan Medicare as a customer, is a buy for the bank. “We believe Convey differentiates itself from competitors as a provider of purpose-built healthcare IT software and services to government-sponsored health plans,” Goldman’s analysts wrote in a July 11 research note. The bank’s 12-month price target is $21, representing a potential 112.6% upside.\nLyell Immunopharma, Inc., which develops cancer therapies, is also buy-rated by the analysts. “We are encouraged by the preclinical data seen to-date and the experienced management team and note multiple programs are set to enter the clinic with first-in-human data next year,” Goldman’s analysts said in a July 12 research note. The bank’s 12-month price target is $30, representing a potential upside of 88.9%.\nOther new healthcare stocks Goldman picked include Chinese biotech firm CARSGEN-B, with a 12-month price target of 48.72 Hong Kong dollars ($6.25) — a potential upside of 62.7% — and Chinese firm AmoyDx, with a 12-month price target of 140 yuan renminbi ($21.52), a potential upside of 66.7%.\nTechnology\nDigital support company TaskUs Inc. is buy-rated, with Goldman giving it a 12-month price target of $61, a potential upside of 88.3%. The firm helps manage customer service for the likes of Zoom, which hired the company as the coronavirus pandemic struck in 2020. “We believe there is potential, given its historically high net retention rate, for it to grow above the consensus growth rates of its clients,” the bank’s analysts wrote in a July 6 note.\nGoldman gave IronSource Ltd, a “fast growing mobile ad platform at scaled margins,” a 12-month price target of $11, a potential upside of 23.7%. The company went public in Marchvia a special-purpose acquisition vehicle (SPAC)and the bank said it would benefit from growth in mobile apps and also liked its game development arm Sonic Publishing.\nSentinelOne, Inc, which debuted on the New York Stock Exchange in June and wasthe highest-valued cybersecurity IPO ever, is also buy-rated by the bank. Goldman described it as “a best of breed, founder-led XDR [extended detection and response] leader in one of the most attractive segments within Security Software,” in a July 25 research note. The bank gave the stock a 12-month price target of $57, a potential upside of 22.4%.\nGoldman also picked “leading” Chinese firm JD LOGISTICS— which became a separate entity to retail giant JD.com in 2017 — andlisted on the Hong Kong stock exchange in May. Goldman expects it to double its market share by 2025, growing via investments in supply chain technology, overseas expansion and additions to its air cargo network. The bank’s 12-month price target is 58.50 Hong Kong dollars, representing a potential upside of 38.3%.\nGoldman also likes Nasdaq-listed Turkish e-commerce giant Hepsiburada, with a 12-month price target of $25.90 — a potential upside of 95% — and Chinese electronics seller AiHuiShou, with a 12-month price target of $20.80, representing a potential upside of 48.1%.\nApparel\nGoldman started covering several apparel stocks this month and said the sector has “macro tailwinds from a strong consumer and supportive discretionary retail spend,” in a July 14 note to investors.\nAthleisure company Lululemon Athletica on Goldman’s conviction list, with the bank describing it as “a leader in driving online to offline consumer connection,” giving it a buy rating. The analysts likedits $500 million acquisition of fitness screen company Mirror, and gave the stock a $447 12-month target price, a potential upside of 21%.\nLuxury label Ralph Lauren has “potential upside” from digital sales via its own websites, according to Goldman, which is “upbeat” about the company’s turnaround, and it gave it a buy rating. The bank’s 12-month price target is $147, a potential upside of 28%.\nGoldman is also buy-rated on Calvin Klein owner PVH Corp, due to the company’s e-commerce focus, new management and pandemic restructuring, expecting the firm to provide “stronger” margins. The bank gave the stock a 12-month price target of $127, a potential upside of 21%.\nLevi Strauss & Co is a buy for the bank, which liked its “best-in-class heritage positioning.” “LEVI is emerging from the pandemic with a better-positioned US wholesale marketplace, a more agile organization with increased digital tools and a faster go-to-market,” Goldman said. Its 12-month price target is $36, a potential upside of 25%.\nMedia\nGoldman started covering concert promoter Live Nation Entertainment on July 15. “We initiate coverage on Live Nation (“LYV”) with a Buy rating and 12-month price target of $110, implying 35% total potential return,” the bank said. Goldman expects an uptick inlive events after the pandemicand sees growth opportunities in high-margin merchandise and VIP experiences.\nThe bank also likes audio firm iHeartMedia, Inc., calling it a “most undiscovered” stock, and “the leading multi-platform audio media company in the U.S.” “We initiate coverage on iHeartMedia (“IHRT”) with a Buy rating and a 12-month price target of $32, representing 25% total potential return,” the analysts said in a July 15 research note.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5400451,"gmtCreate":1627880600763,"gmtModify":1663231809568,"authorId":3571345352614779,"author":{"id":3571345352614779,"authorId":3571345352614779,"name":"xiaobaii","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805646470,"type":1,"supId":0,"prevId":0,"content":"like &amp; comment please, thank you very much ","text":"like &amp; comment please, thank you very much ","html":"like &amp; comment please, thank you very much "}],"langContent":"EN"},{"id":805649694,"gmtCreate":1627878916018,"gmtModify":1703497061578,"author":{"id":"3581844366704770","authorId":"3581844366704770","authorIdStr":"3581844366704770","name":"KingKong88","avatar":"https://static.tigerbbs.com/ca221e1f8c3c6fd2bccd3f8d4d7b5bdb","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3581844366704770"},"htmlText":"Hmm...&nbsp;[思考]&nbsp;","listText":"Hmm...&nbsp;[思考]&nbsp;","text":"Hmm... [思考]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/805649694","repostId":1125617093,"repostType":4,"repost":{"id":"1125617093","pubTimestamp":1627875620,"share":"https://ttm.financial/m/news/1125617093?lang=&edition=fundamental","pubTime":"2021-08-02 11:40","market":"us","language":"en","title":"Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside","url":"https://stock-news.laohu8.com/highlight/detail?id=1125617093","media":"CNBC","summary":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health ","content":"<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs picks new stocks to buy from tech to health — some with over 100% upside\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 11:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"S":"SentinelOne, Inc","LULU":"lululemon athletica","AMAM":"Ambrx Biopharma Inc","LYEL":"Lyell Immunopharma, Inc.","TASK":"TaskUs Inc.","ZM":"Zoom","IS":"IronSource Ltd","02618":"京东物流","LYV":"Live Nation Entertainment","PVH":"PVH Corp","RL":"拉夫劳伦","02171":"科济药业-B","LEVI":"李维斯","IHRT":"iHeartMedia, Inc.","GS":"高盛"},"source_url":"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1125617093","content_text":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is buy-rated on about 45 — and some have a potential upside of over 100%.\nGoldman’s analysts initiated coverage on newly-listed companies that debuted on the stock market in the past few months, and also started providing research on some big-name apparel and media brands. Here’s a selection.\nHealth care\nU.S. insurance firm Bright Health Group, which operates insurance tech software as well as a platform connecting patients with health providers is buy-rated by the bank and raised nearly $1 billionin an initial public offering (IPO) in May. Goldman said it sees more than 100% upside to the share price from its current levels over 12 months, while trading at a “healthy” discount to other rapidly-growing insurers, according to a July 19 research note.\nGoldman also likes Ambrx Biopharma Inc, a cancer biotech firm, for its “pioneering research”, “unique and differentiated platform technology” and partnerships with pharmaceuticals companies such as Bristol Myers Squibb. The bank’s 12-month price target is $53, representing a 148.8% potential upside, the analysts said in a July 13 research note.\nHealth tech company Convey Holding Parent, Inc., which counts the likes of U.S. government insurance plan Medicare as a customer, is a buy for the bank. “We believe Convey differentiates itself from competitors as a provider of purpose-built healthcare IT software and services to government-sponsored health plans,” Goldman’s analysts wrote in a July 11 research note. The bank’s 12-month price target is $21, representing a potential 112.6% upside.\nLyell Immunopharma, Inc., which develops cancer therapies, is also buy-rated by the analysts. “We are encouraged by the preclinical data seen to-date and the experienced management team and note multiple programs are set to enter the clinic with first-in-human data next year,” Goldman’s analysts said in a July 12 research note. The bank’s 12-month price target is $30, representing a potential upside of 88.9%.\nOther new healthcare stocks Goldman picked include Chinese biotech firm CARSGEN-B, with a 12-month price target of 48.72 Hong Kong dollars ($6.25) — a potential upside of 62.7% — and Chinese firm AmoyDx, with a 12-month price target of 140 yuan renminbi ($21.52), a potential upside of 66.7%.\nTechnology\nDigital support company TaskUs Inc. is buy-rated, with Goldman giving it a 12-month price target of $61, a potential upside of 88.3%. The firm helps manage customer service for the likes of Zoom, which hired the company as the coronavirus pandemic struck in 2020. “We believe there is potential, given its historically high net retention rate, for it to grow above the consensus growth rates of its clients,” the bank’s analysts wrote in a July 6 note.\nGoldman gave IronSource Ltd, a “fast growing mobile ad platform at scaled margins,” a 12-month price target of $11, a potential upside of 23.7%. The company went public in Marchvia a special-purpose acquisition vehicle (SPAC)and the bank said it would benefit from growth in mobile apps and also liked its game development arm Sonic Publishing.\nSentinelOne, Inc, which debuted on the New York Stock Exchange in June and wasthe highest-valued cybersecurity IPO ever, is also buy-rated by the bank. Goldman described it as “a best of breed, founder-led XDR [extended detection and response] leader in one of the most attractive segments within Security Software,” in a July 25 research note. The bank gave the stock a 12-month price target of $57, a potential upside of 22.4%.\nGoldman also picked “leading” Chinese firm JD LOGISTICS— which became a separate entity to retail giant JD.com in 2017 — andlisted on the Hong Kong stock exchange in May. Goldman expects it to double its market share by 2025, growing via investments in supply chain technology, overseas expansion and additions to its air cargo network. The bank’s 12-month price target is 58.50 Hong Kong dollars, representing a potential upside of 38.3%.\nGoldman also likes Nasdaq-listed Turkish e-commerce giant Hepsiburada, with a 12-month price target of $25.90 — a potential upside of 95% — and Chinese electronics seller AiHuiShou, with a 12-month price target of $20.80, representing a potential upside of 48.1%.\nApparel\nGoldman started covering several apparel stocks this month and said the sector has “macro tailwinds from a strong consumer and supportive discretionary retail spend,” in a July 14 note to investors.\nAthleisure company Lululemon Athletica on Goldman’s conviction list, with the bank describing it as “a leader in driving online to offline consumer connection,” giving it a buy rating. The analysts likedits $500 million acquisition of fitness screen company Mirror, and gave the stock a $447 12-month target price, a potential upside of 21%.\nLuxury label Ralph Lauren has “potential upside” from digital sales via its own websites, according to Goldman, which is “upbeat” about the company’s turnaround, and it gave it a buy rating. The bank’s 12-month price target is $147, a potential upside of 28%.\nGoldman is also buy-rated on Calvin Klein owner PVH Corp, due to the company’s e-commerce focus, new management and pandemic restructuring, expecting the firm to provide “stronger” margins. The bank gave the stock a 12-month price target of $127, a potential upside of 21%.\nLevi Strauss & Co is a buy for the bank, which liked its “best-in-class heritage positioning.” “LEVI is emerging from the pandemic with a better-positioned US wholesale marketplace, a more agile organization with increased digital tools and a faster go-to-market,” Goldman said. Its 12-month price target is $36, a potential upside of 25%.\nMedia\nGoldman started covering concert promoter Live Nation Entertainment on July 15. “We initiate coverage on Live Nation (“LYV”) with a Buy rating and 12-month price target of $110, implying 35% total potential return,” the bank said. Goldman expects an uptick inlive events after the pandemicand sees growth opportunities in high-margin merchandise and VIP experiences.\nThe bank also likes audio firm iHeartMedia, Inc., calling it a “most undiscovered” stock, and “the leading multi-platform audio media company in the U.S.” “We initiate coverage on iHeartMedia (“IHRT”) with a Buy rating and a 12-month price target of $32, representing 25% total potential return,” the analysts said in a July 15 research note.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5400266,"gmtCreate":1627879075934,"gmtModify":1663231811338,"authorId":3581746780935690,"author":{"id":3581746780935690,"authorId":3581746780935690,"name":"qstocks","avatar":"https://static.tigerbbs.com/cd471dd6c55721dad90e1c808f35bdd8","vip":1,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.13","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":2,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805649694,"type":1,"supId":0,"prevId":0,"content":"like","text":"like","html":"like"},{"id":5400346,"gmtCreate":1627879719507,"gmtModify":1663231810736,"authorId":3572945845916163,"author":{"id":3572945845916163,"authorId":3572945845916163,"name":"NareshwG","avatar":"https://static.tigerbbs.com/0d6dc06165c1a0cc4f1a8169ea48573d","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805649694,"type":1,"supId":0,"prevId":0,"content":"Same here..","text":"Same here..","html":"Same here.."},{"id":5400452,"gmtCreate":1627880606797,"gmtModify":1663231810638,"authorId":3571345352614779,"author":{"id":3571345352614779,"authorId":3571345352614779,"name":"xiaobaii","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805649694,"type":1,"supId":0,"prevId":0,"content":"like &amp; comment please, thank you very much ","text":"like &amp; comment please, thank you very much ","html":"like &amp; comment please, thank you very much "}],"langContent":"CN"},{"id":805640563,"gmtCreate":1627878819252,"gmtModify":1703497060578,"author":{"id":"4090981439099540","authorId":"4090981439099540","authorIdStr":"4090981439099540","name":"JennyTan","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"4090981439099540"},"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/805640563","repostId":1125617093,"repostType":4,"repost":{"id":"1125617093","pubTimestamp":1627875620,"share":"https://ttm.financial/m/news/1125617093?lang=&edition=fundamental","pubTime":"2021-08-02 11:40","market":"us","language":"en","title":"Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside","url":"https://stock-news.laohu8.com/highlight/detail?id=1125617093","media":"CNBC","summary":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health ","content":"<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs picks new stocks to buy from tech to health — some with over 100% upside\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 11:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"S":"SentinelOne, Inc","LULU":"lululemon athletica","AMAM":"Ambrx Biopharma Inc","LYEL":"Lyell Immunopharma, Inc.","TASK":"TaskUs Inc.","ZM":"Zoom","IS":"IronSource Ltd","02618":"京东物流","LYV":"Live Nation Entertainment","PVH":"PVH Corp","RL":"拉夫劳伦","02171":"科济药业-B","LEVI":"李维斯","IHRT":"iHeartMedia, Inc.","GS":"高盛"},"source_url":"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1125617093","content_text":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is buy-rated on about 45 — and some have a potential upside of over 100%.\nGoldman’s analysts initiated coverage on newly-listed companies that debuted on the stock market in the past few months, and also started providing research on some big-name apparel and media brands. Here’s a selection.\nHealth care\nU.S. insurance firm Bright Health Group, which operates insurance tech software as well as a platform connecting patients with health providers is buy-rated by the bank and raised nearly $1 billionin an initial public offering (IPO) in May. Goldman said it sees more than 100% upside to the share price from its current levels over 12 months, while trading at a “healthy” discount to other rapidly-growing insurers, according to a July 19 research note.\nGoldman also likes Ambrx Biopharma Inc, a cancer biotech firm, for its “pioneering research”, “unique and differentiated platform technology” and partnerships with pharmaceuticals companies such as Bristol Myers Squibb. The bank’s 12-month price target is $53, representing a 148.8% potential upside, the analysts said in a July 13 research note.\nHealth tech company Convey Holding Parent, Inc., which counts the likes of U.S. government insurance plan Medicare as a customer, is a buy for the bank. “We believe Convey differentiates itself from competitors as a provider of purpose-built healthcare IT software and services to government-sponsored health plans,” Goldman’s analysts wrote in a July 11 research note. The bank’s 12-month price target is $21, representing a potential 112.6% upside.\nLyell Immunopharma, Inc., which develops cancer therapies, is also buy-rated by the analysts. “We are encouraged by the preclinical data seen to-date and the experienced management team and note multiple programs are set to enter the clinic with first-in-human data next year,” Goldman’s analysts said in a July 12 research note. The bank’s 12-month price target is $30, representing a potential upside of 88.9%.\nOther new healthcare stocks Goldman picked include Chinese biotech firm CARSGEN-B, with a 12-month price target of 48.72 Hong Kong dollars ($6.25) — a potential upside of 62.7% — and Chinese firm AmoyDx, with a 12-month price target of 140 yuan renminbi ($21.52), a potential upside of 66.7%.\nTechnology\nDigital support company TaskUs Inc. is buy-rated, with Goldman giving it a 12-month price target of $61, a potential upside of 88.3%. The firm helps manage customer service for the likes of Zoom, which hired the company as the coronavirus pandemic struck in 2020. “We believe there is potential, given its historically high net retention rate, for it to grow above the consensus growth rates of its clients,” the bank’s analysts wrote in a July 6 note.\nGoldman gave IronSource Ltd, a “fast growing mobile ad platform at scaled margins,” a 12-month price target of $11, a potential upside of 23.7%. The company went public in Marchvia a special-purpose acquisition vehicle (SPAC)and the bank said it would benefit from growth in mobile apps and also liked its game development arm Sonic Publishing.\nSentinelOne, Inc, which debuted on the New York Stock Exchange in June and wasthe highest-valued cybersecurity IPO ever, is also buy-rated by the bank. Goldman described it as “a best of breed, founder-led XDR [extended detection and response] leader in one of the most attractive segments within Security Software,” in a July 25 research note. The bank gave the stock a 12-month price target of $57, a potential upside of 22.4%.\nGoldman also picked “leading” Chinese firm JD LOGISTICS— which became a separate entity to retail giant JD.com in 2017 — andlisted on the Hong Kong stock exchange in May. Goldman expects it to double its market share by 2025, growing via investments in supply chain technology, overseas expansion and additions to its air cargo network. The bank’s 12-month price target is 58.50 Hong Kong dollars, representing a potential upside of 38.3%.\nGoldman also likes Nasdaq-listed Turkish e-commerce giant Hepsiburada, with a 12-month price target of $25.90 — a potential upside of 95% — and Chinese electronics seller AiHuiShou, with a 12-month price target of $20.80, representing a potential upside of 48.1%.\nApparel\nGoldman started covering several apparel stocks this month and said the sector has “macro tailwinds from a strong consumer and supportive discretionary retail spend,” in a July 14 note to investors.\nAthleisure company Lululemon Athletica on Goldman’s conviction list, with the bank describing it as “a leader in driving online to offline consumer connection,” giving it a buy rating. The analysts likedits $500 million acquisition of fitness screen company Mirror, and gave the stock a $447 12-month target price, a potential upside of 21%.\nLuxury label Ralph Lauren has “potential upside” from digital sales via its own websites, according to Goldman, which is “upbeat” about the company’s turnaround, and it gave it a buy rating. The bank’s 12-month price target is $147, a potential upside of 28%.\nGoldman is also buy-rated on Calvin Klein owner PVH Corp, due to the company’s e-commerce focus, new management and pandemic restructuring, expecting the firm to provide “stronger” margins. The bank gave the stock a 12-month price target of $127, a potential upside of 21%.\nLevi Strauss & Co is a buy for the bank, which liked its “best-in-class heritage positioning.” “LEVI is emerging from the pandemic with a better-positioned US wholesale marketplace, a more agile organization with increased digital tools and a faster go-to-market,” Goldman said. Its 12-month price target is $36, a potential upside of 25%.\nMedia\nGoldman started covering concert promoter Live Nation Entertainment on July 15. “We initiate coverage on Live Nation (“LYV”) with a Buy rating and 12-month price target of $110, implying 35% total potential return,” the bank said. Goldman expects an uptick inlive events after the pandemicand sees growth opportunities in high-margin merchandise and VIP experiences.\nThe bank also likes audio firm iHeartMedia, Inc., calling it a “most undiscovered” stock, and “the leading multi-platform audio media company in the U.S.” “We initiate coverage on iHeartMedia (“IHRT”) with a Buy rating and a 12-month price target of $32, representing 25% total potential return,” the analysts said in a July 15 research note.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5400453,"gmtCreate":1627880612071,"gmtModify":1663231810728,"authorId":3571345352614779,"author":{"id":3571345352614779,"authorId":3571345352614779,"name":"xiaobaii","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805640563,"type":1,"supId":0,"prevId":0,"content":"like &amp; comment please, thank you very much ","text":"like &amp; comment please, thank you very much ","html":"like &amp; comment please, thank you very much "}],"langContent":"EN"},{"id":805640162,"gmtCreate":1627878798656,"gmtModify":1703497059412,"author":{"id":"4087816289268270","authorId":"4087816289268270","authorIdStr":"4087816289268270","name":"Valerie1209","avatar":"https://static.tigerbbs.com/2723c02ea30836f743fae4b42690778e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4087816289268270"},"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/805640162","repostId":1125617093,"repostType":4,"repost":{"id":"1125617093","pubTimestamp":1627875620,"share":"https://ttm.financial/m/news/1125617093?lang=&edition=fundamental","pubTime":"2021-08-02 11:40","market":"us","language":"en","title":"Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside","url":"https://stock-news.laohu8.com/highlight/detail?id=1125617093","media":"CNBC","summary":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health ","content":"<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs picks new stocks to buy from tech to health — some with over 100% upside\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 11:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"S":"SentinelOne, Inc","LULU":"lululemon athletica","AMAM":"Ambrx Biopharma Inc","LYEL":"Lyell Immunopharma, Inc.","TASK":"TaskUs Inc.","ZM":"Zoom","IS":"IronSource Ltd","02618":"京东物流","LYV":"Live Nation Entertainment","PVH":"PVH Corp","RL":"拉夫劳伦","02171":"科济药业-B","LEVI":"李维斯","IHRT":"iHeartMedia, Inc.","GS":"高盛"},"source_url":"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1125617093","content_text":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is buy-rated on about 45 — and some have a potential upside of over 100%.\nGoldman’s analysts initiated coverage on newly-listed companies that debuted on the stock market in the past few months, and also started providing research on some big-name apparel and media brands. Here’s a selection.\nHealth care\nU.S. insurance firm Bright Health Group, which operates insurance tech software as well as a platform connecting patients with health providers is buy-rated by the bank and raised nearly $1 billionin an initial public offering (IPO) in May. Goldman said it sees more than 100% upside to the share price from its current levels over 12 months, while trading at a “healthy” discount to other rapidly-growing insurers, according to a July 19 research note.\nGoldman also likes Ambrx Biopharma Inc, a cancer biotech firm, for its “pioneering research”, “unique and differentiated platform technology” and partnerships with pharmaceuticals companies such as Bristol Myers Squibb. The bank’s 12-month price target is $53, representing a 148.8% potential upside, the analysts said in a July 13 research note.\nHealth tech company Convey Holding Parent, Inc., which counts the likes of U.S. government insurance plan Medicare as a customer, is a buy for the bank. “We believe Convey differentiates itself from competitors as a provider of purpose-built healthcare IT software and services to government-sponsored health plans,” Goldman’s analysts wrote in a July 11 research note. The bank’s 12-month price target is $21, representing a potential 112.6% upside.\nLyell Immunopharma, Inc., which develops cancer therapies, is also buy-rated by the analysts. “We are encouraged by the preclinical data seen to-date and the experienced management team and note multiple programs are set to enter the clinic with first-in-human data next year,” Goldman’s analysts said in a July 12 research note. The bank’s 12-month price target is $30, representing a potential upside of 88.9%.\nOther new healthcare stocks Goldman picked include Chinese biotech firm CARSGEN-B, with a 12-month price target of 48.72 Hong Kong dollars ($6.25) — a potential upside of 62.7% — and Chinese firm AmoyDx, with a 12-month price target of 140 yuan renminbi ($21.52), a potential upside of 66.7%.\nTechnology\nDigital support company TaskUs Inc. is buy-rated, with Goldman giving it a 12-month price target of $61, a potential upside of 88.3%. The firm helps manage customer service for the likes of Zoom, which hired the company as the coronavirus pandemic struck in 2020. “We believe there is potential, given its historically high net retention rate, for it to grow above the consensus growth rates of its clients,” the bank’s analysts wrote in a July 6 note.\nGoldman gave IronSource Ltd, a “fast growing mobile ad platform at scaled margins,” a 12-month price target of $11, a potential upside of 23.7%. The company went public in Marchvia a special-purpose acquisition vehicle (SPAC)and the bank said it would benefit from growth in mobile apps and also liked its game development arm Sonic Publishing.\nSentinelOne, Inc, which debuted on the New York Stock Exchange in June and wasthe highest-valued cybersecurity IPO ever, is also buy-rated by the bank. Goldman described it as “a best of breed, founder-led XDR [extended detection and response] leader in one of the most attractive segments within Security Software,” in a July 25 research note. The bank gave the stock a 12-month price target of $57, a potential upside of 22.4%.\nGoldman also picked “leading” Chinese firm JD LOGISTICS— which became a separate entity to retail giant JD.com in 2017 — andlisted on the Hong Kong stock exchange in May. Goldman expects it to double its market share by 2025, growing via investments in supply chain technology, overseas expansion and additions to its air cargo network. The bank’s 12-month price target is 58.50 Hong Kong dollars, representing a potential upside of 38.3%.\nGoldman also likes Nasdaq-listed Turkish e-commerce giant Hepsiburada, with a 12-month price target of $25.90 — a potential upside of 95% — and Chinese electronics seller AiHuiShou, with a 12-month price target of $20.80, representing a potential upside of 48.1%.\nApparel\nGoldman started covering several apparel stocks this month and said the sector has “macro tailwinds from a strong consumer and supportive discretionary retail spend,” in a July 14 note to investors.\nAthleisure company Lululemon Athletica on Goldman’s conviction list, with the bank describing it as “a leader in driving online to offline consumer connection,” giving it a buy rating. The analysts likedits $500 million acquisition of fitness screen company Mirror, and gave the stock a $447 12-month target price, a potential upside of 21%.\nLuxury label Ralph Lauren has “potential upside” from digital sales via its own websites, according to Goldman, which is “upbeat” about the company’s turnaround, and it gave it a buy rating. The bank’s 12-month price target is $147, a potential upside of 28%.\nGoldman is also buy-rated on Calvin Klein owner PVH Corp, due to the company’s e-commerce focus, new management and pandemic restructuring, expecting the firm to provide “stronger” margins. The bank gave the stock a 12-month price target of $127, a potential upside of 21%.\nLevi Strauss & Co is a buy for the bank, which liked its “best-in-class heritage positioning.” “LEVI is emerging from the pandemic with a better-positioned US wholesale marketplace, a more agile organization with increased digital tools and a faster go-to-market,” Goldman said. Its 12-month price target is $36, a potential upside of 25%.\nMedia\nGoldman started covering concert promoter Live Nation Entertainment on July 15. “We initiate coverage on Live Nation (“LYV”) with a Buy rating and 12-month price target of $110, implying 35% total potential return,” the bank said. Goldman expects an uptick inlive events after the pandemicand sees growth opportunities in high-margin merchandise and VIP experiences.\nThe bank also likes audio firm iHeartMedia, Inc., calling it a “most undiscovered” stock, and “the leading multi-platform audio media company in the U.S.” “We initiate coverage on iHeartMedia (“IHRT”) with a Buy rating and a 12-month price target of $32, representing 25% total potential return,” the analysts said in a July 15 research note.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":805656037,"gmtCreate":1627878344629,"gmtModify":1703497052974,"author":{"id":"3580379447244817","authorId":"3580379447244817","authorIdStr":"3580379447244817","name":"Haw75","avatar":"https://static.tigerbbs.com/b8a435feb2331b895463eca3c73cdb3f","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3580379447244817"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/805656037","repostId":1125617093,"repostType":4,"repost":{"id":"1125617093","pubTimestamp":1627875620,"share":"https://ttm.financial/m/news/1125617093?lang=&edition=fundamental","pubTime":"2021-08-02 11:40","market":"us","language":"en","title":"Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside","url":"https://stock-news.laohu8.com/highlight/detail?id=1125617093","media":"CNBC","summary":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health ","content":"<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs picks new stocks to buy from tech to health — some with over 100% upside\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 11:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"S":"SentinelOne, Inc","LULU":"lululemon athletica","AMAM":"Ambrx Biopharma Inc","LYEL":"Lyell Immunopharma, Inc.","TASK":"TaskUs Inc.","ZM":"Zoom","IS":"IronSource Ltd","02618":"京东物流","LYV":"Live Nation Entertainment","PVH":"PVH Corp","RL":"拉夫劳伦","02171":"科济药业-B","LEVI":"李维斯","IHRT":"iHeartMedia, Inc.","GS":"高盛"},"source_url":"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1125617093","content_text":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is buy-rated on about 45 — and some have a potential upside of over 100%.\nGoldman’s analysts initiated coverage on newly-listed companies that debuted on the stock market in the past few months, and also started providing research on some big-name apparel and media brands. Here’s a selection.\nHealth care\nU.S. insurance firm Bright Health Group, which operates insurance tech software as well as a platform connecting patients with health providers is buy-rated by the bank and raised nearly $1 billionin an initial public offering (IPO) in May. Goldman said it sees more than 100% upside to the share price from its current levels over 12 months, while trading at a “healthy” discount to other rapidly-growing insurers, according to a July 19 research note.\nGoldman also likes Ambrx Biopharma Inc, a cancer biotech firm, for its “pioneering research”, “unique and differentiated platform technology” and partnerships with pharmaceuticals companies such as Bristol Myers Squibb. The bank’s 12-month price target is $53, representing a 148.8% potential upside, the analysts said in a July 13 research note.\nHealth tech company Convey Holding Parent, Inc., which counts the likes of U.S. government insurance plan Medicare as a customer, is a buy for the bank. “We believe Convey differentiates itself from competitors as a provider of purpose-built healthcare IT software and services to government-sponsored health plans,” Goldman’s analysts wrote in a July 11 research note. The bank’s 12-month price target is $21, representing a potential 112.6% upside.\nLyell Immunopharma, Inc., which develops cancer therapies, is also buy-rated by the analysts. “We are encouraged by the preclinical data seen to-date and the experienced management team and note multiple programs are set to enter the clinic with first-in-human data next year,” Goldman’s analysts said in a July 12 research note. The bank’s 12-month price target is $30, representing a potential upside of 88.9%.\nOther new healthcare stocks Goldman picked include Chinese biotech firm CARSGEN-B, with a 12-month price target of 48.72 Hong Kong dollars ($6.25) — a potential upside of 62.7% — and Chinese firm AmoyDx, with a 12-month price target of 140 yuan renminbi ($21.52), a potential upside of 66.7%.\nTechnology\nDigital support company TaskUs Inc. is buy-rated, with Goldman giving it a 12-month price target of $61, a potential upside of 88.3%. The firm helps manage customer service for the likes of Zoom, which hired the company as the coronavirus pandemic struck in 2020. “We believe there is potential, given its historically high net retention rate, for it to grow above the consensus growth rates of its clients,” the bank’s analysts wrote in a July 6 note.\nGoldman gave IronSource Ltd, a “fast growing mobile ad platform at scaled margins,” a 12-month price target of $11, a potential upside of 23.7%. The company went public in Marchvia a special-purpose acquisition vehicle (SPAC)and the bank said it would benefit from growth in mobile apps and also liked its game development arm Sonic Publishing.\nSentinelOne, Inc, which debuted on the New York Stock Exchange in June and wasthe highest-valued cybersecurity IPO ever, is also buy-rated by the bank. Goldman described it as “a best of breed, founder-led XDR [extended detection and response] leader in one of the most attractive segments within Security Software,” in a July 25 research note. The bank gave the stock a 12-month price target of $57, a potential upside of 22.4%.\nGoldman also picked “leading” Chinese firm JD LOGISTICS— which became a separate entity to retail giant JD.com in 2017 — andlisted on the Hong Kong stock exchange in May. Goldman expects it to double its market share by 2025, growing via investments in supply chain technology, overseas expansion and additions to its air cargo network. The bank’s 12-month price target is 58.50 Hong Kong dollars, representing a potential upside of 38.3%.\nGoldman also likes Nasdaq-listed Turkish e-commerce giant Hepsiburada, with a 12-month price target of $25.90 — a potential upside of 95% — and Chinese electronics seller AiHuiShou, with a 12-month price target of $20.80, representing a potential upside of 48.1%.\nApparel\nGoldman started covering several apparel stocks this month and said the sector has “macro tailwinds from a strong consumer and supportive discretionary retail spend,” in a July 14 note to investors.\nAthleisure company Lululemon Athletica on Goldman’s conviction list, with the bank describing it as “a leader in driving online to offline consumer connection,” giving it a buy rating. The analysts likedits $500 million acquisition of fitness screen company Mirror, and gave the stock a $447 12-month target price, a potential upside of 21%.\nLuxury label Ralph Lauren has “potential upside” from digital sales via its own websites, according to Goldman, which is “upbeat” about the company’s turnaround, and it gave it a buy rating. The bank’s 12-month price target is $147, a potential upside of 28%.\nGoldman is also buy-rated on Calvin Klein owner PVH Corp, due to the company’s e-commerce focus, new management and pandemic restructuring, expecting the firm to provide “stronger” margins. The bank gave the stock a 12-month price target of $127, a potential upside of 21%.\nLevi Strauss & Co is a buy for the bank, which liked its “best-in-class heritage positioning.” “LEVI is emerging from the pandemic with a better-positioned US wholesale marketplace, a more agile organization with increased digital tools and a faster go-to-market,” Goldman said. Its 12-month price target is $36, a potential upside of 25%.\nMedia\nGoldman started covering concert promoter Live Nation Entertainment on July 15. “We initiate coverage on Live Nation (“LYV”) with a Buy rating and 12-month price target of $110, implying 35% total potential return,” the bank said. Goldman expects an uptick inlive events after the pandemicand sees growth opportunities in high-margin merchandise and VIP experiences.\nThe bank also likes audio firm iHeartMedia, Inc., calling it a “most undiscovered” stock, and “the leading multi-platform audio media company in the U.S.” “We initiate coverage on iHeartMedia (“IHRT”) with a Buy rating and a 12-month price target of $32, representing 25% total potential return,” the analysts said in a July 15 research note.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5400237,"gmtCreate":1627878727843,"gmtModify":1663231810646,"authorId":4089071665449880,"author":{"id":4089071665449880,"authorId":4089071665449880,"name":"gstrader","avatar":"https://static.tigerbbs.com/bc1dc8a3139d4e25f88ab3d2add3f335","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805656037,"type":1,"supId":0,"prevId":0,"content":"great","text":"great","html":"great"}],"langContent":"EN"},{"id":805650257,"gmtCreate":1627878016079,"gmtModify":1703497045681,"author":{"id":"3573265010793105","authorId":"3573265010793105","authorIdStr":"3573265010793105","name":"doubleDees","avatar":"https://static.tigerbbs.com/2c61dade65d42065972c6833062a92ed","vip":1,"crmLevel":5,"crmLevelSwitch":1,"idStr":"3573265010793105"},"htmlText":"Like please. Thanks","listText":"Like please. Thanks","text":"Like please. Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/805650257","repostId":1125617093,"repostType":4,"repost":{"id":"1125617093","pubTimestamp":1627875620,"share":"https://ttm.financial/m/news/1125617093?lang=&edition=fundamental","pubTime":"2021-08-02 11:40","market":"us","language":"en","title":"Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside","url":"https://stock-news.laohu8.com/highlight/detail?id=1125617093","media":"CNBC","summary":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health ","content":"<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs picks new stocks to buy from tech to health — some with over 100% upside\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 11:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"S":"SentinelOne, Inc","LULU":"lululemon athletica","AMAM":"Ambrx Biopharma Inc","LYEL":"Lyell Immunopharma, Inc.","TASK":"TaskUs Inc.","ZM":"Zoom","IS":"IronSource Ltd","02618":"京东物流","LYV":"Live Nation Entertainment","PVH":"PVH Corp","RL":"拉夫劳伦","02171":"科济药业-B","LEVI":"李维斯","IHRT":"iHeartMedia, Inc.","GS":"高盛"},"source_url":"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1125617093","content_text":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is buy-rated on about 45 — and some have a potential upside of over 100%.\nGoldman’s analysts initiated coverage on newly-listed companies that debuted on the stock market in the past few months, and also started providing research on some big-name apparel and media brands. Here’s a selection.\nHealth care\nU.S. insurance firm Bright Health Group, which operates insurance tech software as well as a platform connecting patients with health providers is buy-rated by the bank and raised nearly $1 billionin an initial public offering (IPO) in May. Goldman said it sees more than 100% upside to the share price from its current levels over 12 months, while trading at a “healthy” discount to other rapidly-growing insurers, according to a July 19 research note.\nGoldman also likes Ambrx Biopharma Inc, a cancer biotech firm, for its “pioneering research”, “unique and differentiated platform technology” and partnerships with pharmaceuticals companies such as Bristol Myers Squibb. The bank’s 12-month price target is $53, representing a 148.8% potential upside, the analysts said in a July 13 research note.\nHealth tech company Convey Holding Parent, Inc., which counts the likes of U.S. government insurance plan Medicare as a customer, is a buy for the bank. “We believe Convey differentiates itself from competitors as a provider of purpose-built healthcare IT software and services to government-sponsored health plans,” Goldman’s analysts wrote in a July 11 research note. The bank’s 12-month price target is $21, representing a potential 112.6% upside.\nLyell Immunopharma, Inc., which develops cancer therapies, is also buy-rated by the analysts. “We are encouraged by the preclinical data seen to-date and the experienced management team and note multiple programs are set to enter the clinic with first-in-human data next year,” Goldman’s analysts said in a July 12 research note. The bank’s 12-month price target is $30, representing a potential upside of 88.9%.\nOther new healthcare stocks Goldman picked include Chinese biotech firm CARSGEN-B, with a 12-month price target of 48.72 Hong Kong dollars ($6.25) — a potential upside of 62.7% — and Chinese firm AmoyDx, with a 12-month price target of 140 yuan renminbi ($21.52), a potential upside of 66.7%.\nTechnology\nDigital support company TaskUs Inc. is buy-rated, with Goldman giving it a 12-month price target of $61, a potential upside of 88.3%. The firm helps manage customer service for the likes of Zoom, which hired the company as the coronavirus pandemic struck in 2020. “We believe there is potential, given its historically high net retention rate, for it to grow above the consensus growth rates of its clients,” the bank’s analysts wrote in a July 6 note.\nGoldman gave IronSource Ltd, a “fast growing mobile ad platform at scaled margins,” a 12-month price target of $11, a potential upside of 23.7%. The company went public in Marchvia a special-purpose acquisition vehicle (SPAC)and the bank said it would benefit from growth in mobile apps and also liked its game development arm Sonic Publishing.\nSentinelOne, Inc, which debuted on the New York Stock Exchange in June and wasthe highest-valued cybersecurity IPO ever, is also buy-rated by the bank. Goldman described it as “a best of breed, founder-led XDR [extended detection and response] leader in one of the most attractive segments within Security Software,” in a July 25 research note. The bank gave the stock a 12-month price target of $57, a potential upside of 22.4%.\nGoldman also picked “leading” Chinese firm JD LOGISTICS— which became a separate entity to retail giant JD.com in 2017 — andlisted on the Hong Kong stock exchange in May. Goldman expects it to double its market share by 2025, growing via investments in supply chain technology, overseas expansion and additions to its air cargo network. The bank’s 12-month price target is 58.50 Hong Kong dollars, representing a potential upside of 38.3%.\nGoldman also likes Nasdaq-listed Turkish e-commerce giant Hepsiburada, with a 12-month price target of $25.90 — a potential upside of 95% — and Chinese electronics seller AiHuiShou, with a 12-month price target of $20.80, representing a potential upside of 48.1%.\nApparel\nGoldman started covering several apparel stocks this month and said the sector has “macro tailwinds from a strong consumer and supportive discretionary retail spend,” in a July 14 note to investors.\nAthleisure company Lululemon Athletica on Goldman’s conviction list, with the bank describing it as “a leader in driving online to offline consumer connection,” giving it a buy rating. The analysts likedits $500 million acquisition of fitness screen company Mirror, and gave the stock a $447 12-month target price, a potential upside of 21%.\nLuxury label Ralph Lauren has “potential upside” from digital sales via its own websites, according to Goldman, which is “upbeat” about the company’s turnaround, and it gave it a buy rating. The bank’s 12-month price target is $147, a potential upside of 28%.\nGoldman is also buy-rated on Calvin Klein owner PVH Corp, due to the company’s e-commerce focus, new management and pandemic restructuring, expecting the firm to provide “stronger” margins. The bank gave the stock a 12-month price target of $127, a potential upside of 21%.\nLevi Strauss & Co is a buy for the bank, which liked its “best-in-class heritage positioning.” “LEVI is emerging from the pandemic with a better-positioned US wholesale marketplace, a more agile organization with increased digital tools and a faster go-to-market,” Goldman said. Its 12-month price target is $36, a potential upside of 25%.\nMedia\nGoldman started covering concert promoter Live Nation Entertainment on July 15. “We initiate coverage on Live Nation (“LYV”) with a Buy rating and 12-month price target of $110, implying 35% total potential return,” the bank said. Goldman expects an uptick inlive events after the pandemicand sees growth opportunities in high-margin merchandise and VIP experiences.\nThe bank also likes audio firm iHeartMedia, Inc., calling it a “most undiscovered” stock, and “the leading multi-platform audio media company in the U.S.” “We initiate coverage on iHeartMedia (“IHRT”) with a Buy rating and a 12-month price target of $32, representing 25% total potential return,” the analysts said in a July 15 research note.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5400164,"gmtCreate":1627878123206,"gmtModify":1663231809944,"authorId":3572866150582582,"author":{"id":3572866150582582,"authorId":3572866150582582,"name":"Darrenneoyo","avatar":"https://static.tigerbbs.com/19498d498955308da03ff537c16af7b0","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.43%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":5,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805650257,"type":1,"supId":0,"prevId":0,"content":"<u>like</u>","text":"<u>like</u>","html":"<u>like</u>"}],"langContent":"EN"},{"id":805622307,"gmtCreate":1627877762009,"gmtModify":1703497039896,"author":{"id":"3580355822639703","authorId":"3580355822639703","authorIdStr":"3580355822639703","name":"Benlaps","avatar":"https://static.tigerbbs.com/a879f9c3b6b6e26df283d14b87c41852","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3580355822639703"},"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/805622307","repostId":1125617093,"repostType":4,"repost":{"id":"1125617093","pubTimestamp":1627875620,"share":"https://ttm.financial/m/news/1125617093?lang=&edition=fundamental","pubTime":"2021-08-02 11:40","market":"us","language":"en","title":"Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside","url":"https://stock-news.laohu8.com/highlight/detail?id=1125617093","media":"CNBC","summary":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health ","content":"<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs picks new stocks to buy from tech to health — some with over 100% upside\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 11:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"S":"SentinelOne, Inc","LULU":"lululemon athletica","AMAM":"Ambrx Biopharma Inc","LYEL":"Lyell Immunopharma, Inc.","TASK":"TaskUs Inc.","ZM":"Zoom","IS":"IronSource Ltd","02618":"京东物流","LYV":"Live Nation Entertainment","PVH":"PVH Corp","RL":"拉夫劳伦","02171":"科济药业-B","LEVI":"李维斯","IHRT":"iHeartMedia, Inc.","GS":"高盛"},"source_url":"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1125617093","content_text":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is buy-rated on about 45 — and some have a potential upside of over 100%.\nGoldman’s analysts initiated coverage on newly-listed companies that debuted on the stock market in the past few months, and also started providing research on some big-name apparel and media brands. Here’s a selection.\nHealth care\nU.S. insurance firm Bright Health Group, which operates insurance tech software as well as a platform connecting patients with health providers is buy-rated by the bank and raised nearly $1 billionin an initial public offering (IPO) in May. Goldman said it sees more than 100% upside to the share price from its current levels over 12 months, while trading at a “healthy” discount to other rapidly-growing insurers, according to a July 19 research note.\nGoldman also likes Ambrx Biopharma Inc, a cancer biotech firm, for its “pioneering research”, “unique and differentiated platform technology” and partnerships with pharmaceuticals companies such as Bristol Myers Squibb. The bank’s 12-month price target is $53, representing a 148.8% potential upside, the analysts said in a July 13 research note.\nHealth tech company Convey Holding Parent, Inc., which counts the likes of U.S. government insurance plan Medicare as a customer, is a buy for the bank. “We believe Convey differentiates itself from competitors as a provider of purpose-built healthcare IT software and services to government-sponsored health plans,” Goldman’s analysts wrote in a July 11 research note. The bank’s 12-month price target is $21, representing a potential 112.6% upside.\nLyell Immunopharma, Inc., which develops cancer therapies, is also buy-rated by the analysts. “We are encouraged by the preclinical data seen to-date and the experienced management team and note multiple programs are set to enter the clinic with first-in-human data next year,” Goldman’s analysts said in a July 12 research note. The bank’s 12-month price target is $30, representing a potential upside of 88.9%.\nOther new healthcare stocks Goldman picked include Chinese biotech firm CARSGEN-B, with a 12-month price target of 48.72 Hong Kong dollars ($6.25) — a potential upside of 62.7% — and Chinese firm AmoyDx, with a 12-month price target of 140 yuan renminbi ($21.52), a potential upside of 66.7%.\nTechnology\nDigital support company TaskUs Inc. is buy-rated, with Goldman giving it a 12-month price target of $61, a potential upside of 88.3%. The firm helps manage customer service for the likes of Zoom, which hired the company as the coronavirus pandemic struck in 2020. “We believe there is potential, given its historically high net retention rate, for it to grow above the consensus growth rates of its clients,” the bank’s analysts wrote in a July 6 note.\nGoldman gave IronSource Ltd, a “fast growing mobile ad platform at scaled margins,” a 12-month price target of $11, a potential upside of 23.7%. The company went public in Marchvia a special-purpose acquisition vehicle (SPAC)and the bank said it would benefit from growth in mobile apps and also liked its game development arm Sonic Publishing.\nSentinelOne, Inc, which debuted on the New York Stock Exchange in June and wasthe highest-valued cybersecurity IPO ever, is also buy-rated by the bank. Goldman described it as “a best of breed, founder-led XDR [extended detection and response] leader in one of the most attractive segments within Security Software,” in a July 25 research note. The bank gave the stock a 12-month price target of $57, a potential upside of 22.4%.\nGoldman also picked “leading” Chinese firm JD LOGISTICS— which became a separate entity to retail giant JD.com in 2017 — andlisted on the Hong Kong stock exchange in May. Goldman expects it to double its market share by 2025, growing via investments in supply chain technology, overseas expansion and additions to its air cargo network. The bank’s 12-month price target is 58.50 Hong Kong dollars, representing a potential upside of 38.3%.\nGoldman also likes Nasdaq-listed Turkish e-commerce giant Hepsiburada, with a 12-month price target of $25.90 — a potential upside of 95% — and Chinese electronics seller AiHuiShou, with a 12-month price target of $20.80, representing a potential upside of 48.1%.\nApparel\nGoldman started covering several apparel stocks this month and said the sector has “macro tailwinds from a strong consumer and supportive discretionary retail spend,” in a July 14 note to investors.\nAthleisure company Lululemon Athletica on Goldman’s conviction list, with the bank describing it as “a leader in driving online to offline consumer connection,” giving it a buy rating. The analysts likedits $500 million acquisition of fitness screen company Mirror, and gave the stock a $447 12-month target price, a potential upside of 21%.\nLuxury label Ralph Lauren has “potential upside” from digital sales via its own websites, according to Goldman, which is “upbeat” about the company’s turnaround, and it gave it a buy rating. The bank’s 12-month price target is $147, a potential upside of 28%.\nGoldman is also buy-rated on Calvin Klein owner PVH Corp, due to the company’s e-commerce focus, new management and pandemic restructuring, expecting the firm to provide “stronger” margins. The bank gave the stock a 12-month price target of $127, a potential upside of 21%.\nLevi Strauss & Co is a buy for the bank, which liked its “best-in-class heritage positioning.” “LEVI is emerging from the pandemic with a better-positioned US wholesale marketplace, a more agile organization with increased digital tools and a faster go-to-market,” Goldman said. Its 12-month price target is $36, a potential upside of 25%.\nMedia\nGoldman started covering concert promoter Live Nation Entertainment on July 15. “We initiate coverage on Live Nation (“LYV”) with a Buy rating and 12-month price target of $110, implying 35% total potential return,” the bank said. Goldman expects an uptick inlive events after the pandemicand sees growth opportunities in high-margin merchandise and VIP experiences.\nThe bank also likes audio firm iHeartMedia, Inc., calling it a “most undiscovered” stock, and “the leading multi-platform audio media company in the U.S.” “We initiate coverage on iHeartMedia (“IHRT”) with a Buy rating and a 12-month price target of $32, representing 25% total potential return,” the analysts said in a July 15 research note.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5400170,"gmtCreate":1627878179985,"gmtModify":1663231809736,"authorId":3581753394687048,"author":{"id":3581753394687048,"authorId":3581753394687048,"name":"Regit126","avatar":"https://static.tigerbbs.com/decc883f891723830791464bf38e9608","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805622307,"type":1,"supId":0,"prevId":0,"content":"a","text":"a","html":"a"}],"langContent":"EN"},{"id":805667028,"gmtCreate":1627877194164,"gmtModify":1703497028324,"author":{"id":"3581913988119713","authorId":"3581913988119713","authorIdStr":"3581913988119713","name":"Roticanai","avatar":"https://static.tigerbbs.com/4da10b7952b9a699e2c4703a67642740","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581913988119713"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/805667028","repostId":1125617093,"repostType":4,"repost":{"id":"1125617093","pubTimestamp":1627875620,"share":"https://ttm.financial/m/news/1125617093?lang=&edition=fundamental","pubTime":"2021-08-02 11:40","market":"us","language":"en","title":"Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside","url":"https://stock-news.laohu8.com/highlight/detail?id=1125617093","media":"CNBC","summary":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health ","content":"<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs picks new stocks to buy from tech to health — some with over 100% upside\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 11:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"S":"SentinelOne, Inc","LULU":"lululemon athletica","AMAM":"Ambrx Biopharma Inc","LYEL":"Lyell Immunopharma, Inc.","TASK":"TaskUs Inc.","ZM":"Zoom","IS":"IronSource Ltd","02618":"京东物流","LYV":"Live Nation Entertainment","PVH":"PVH Corp","RL":"拉夫劳伦","02171":"科济药业-B","LEVI":"李维斯","IHRT":"iHeartMedia, Inc.","GS":"高盛"},"source_url":"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1125617093","content_text":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is buy-rated on about 45 — and some have a potential upside of over 100%.\nGoldman’s analysts initiated coverage on newly-listed companies that debuted on the stock market in the past few months, and also started providing research on some big-name apparel and media brands. Here’s a selection.\nHealth care\nU.S. insurance firm Bright Health Group, which operates insurance tech software as well as a platform connecting patients with health providers is buy-rated by the bank and raised nearly $1 billionin an initial public offering (IPO) in May. Goldman said it sees more than 100% upside to the share price from its current levels over 12 months, while trading at a “healthy” discount to other rapidly-growing insurers, according to a July 19 research note.\nGoldman also likes Ambrx Biopharma Inc, a cancer biotech firm, for its “pioneering research”, “unique and differentiated platform technology” and partnerships with pharmaceuticals companies such as Bristol Myers Squibb. The bank’s 12-month price target is $53, representing a 148.8% potential upside, the analysts said in a July 13 research note.\nHealth tech company Convey Holding Parent, Inc., which counts the likes of U.S. government insurance plan Medicare as a customer, is a buy for the bank. “We believe Convey differentiates itself from competitors as a provider of purpose-built healthcare IT software and services to government-sponsored health plans,” Goldman’s analysts wrote in a July 11 research note. The bank’s 12-month price target is $21, representing a potential 112.6% upside.\nLyell Immunopharma, Inc., which develops cancer therapies, is also buy-rated by the analysts. “We are encouraged by the preclinical data seen to-date and the experienced management team and note multiple programs are set to enter the clinic with first-in-human data next year,” Goldman’s analysts said in a July 12 research note. The bank’s 12-month price target is $30, representing a potential upside of 88.9%.\nOther new healthcare stocks Goldman picked include Chinese biotech firm CARSGEN-B, with a 12-month price target of 48.72 Hong Kong dollars ($6.25) — a potential upside of 62.7% — and Chinese firm AmoyDx, with a 12-month price target of 140 yuan renminbi ($21.52), a potential upside of 66.7%.\nTechnology\nDigital support company TaskUs Inc. is buy-rated, with Goldman giving it a 12-month price target of $61, a potential upside of 88.3%. The firm helps manage customer service for the likes of Zoom, which hired the company as the coronavirus pandemic struck in 2020. “We believe there is potential, given its historically high net retention rate, for it to grow above the consensus growth rates of its clients,” the bank’s analysts wrote in a July 6 note.\nGoldman gave IronSource Ltd, a “fast growing mobile ad platform at scaled margins,” a 12-month price target of $11, a potential upside of 23.7%. The company went public in Marchvia a special-purpose acquisition vehicle (SPAC)and the bank said it would benefit from growth in mobile apps and also liked its game development arm Sonic Publishing.\nSentinelOne, Inc, which debuted on the New York Stock Exchange in June and wasthe highest-valued cybersecurity IPO ever, is also buy-rated by the bank. Goldman described it as “a best of breed, founder-led XDR [extended detection and response] leader in one of the most attractive segments within Security Software,” in a July 25 research note. The bank gave the stock a 12-month price target of $57, a potential upside of 22.4%.\nGoldman also picked “leading” Chinese firm JD LOGISTICS— which became a separate entity to retail giant JD.com in 2017 — andlisted on the Hong Kong stock exchange in May. Goldman expects it to double its market share by 2025, growing via investments in supply chain technology, overseas expansion and additions to its air cargo network. The bank’s 12-month price target is 58.50 Hong Kong dollars, representing a potential upside of 38.3%.\nGoldman also likes Nasdaq-listed Turkish e-commerce giant Hepsiburada, with a 12-month price target of $25.90 — a potential upside of 95% — and Chinese electronics seller AiHuiShou, with a 12-month price target of $20.80, representing a potential upside of 48.1%.\nApparel\nGoldman started covering several apparel stocks this month and said the sector has “macro tailwinds from a strong consumer and supportive discretionary retail spend,” in a July 14 note to investors.\nAthleisure company Lululemon Athletica on Goldman’s conviction list, with the bank describing it as “a leader in driving online to offline consumer connection,” giving it a buy rating. The analysts likedits $500 million acquisition of fitness screen company Mirror, and gave the stock a $447 12-month target price, a potential upside of 21%.\nLuxury label Ralph Lauren has “potential upside” from digital sales via its own websites, according to Goldman, which is “upbeat” about the company’s turnaround, and it gave it a buy rating. The bank’s 12-month price target is $147, a potential upside of 28%.\nGoldman is also buy-rated on Calvin Klein owner PVH Corp, due to the company’s e-commerce focus, new management and pandemic restructuring, expecting the firm to provide “stronger” margins. The bank gave the stock a 12-month price target of $127, a potential upside of 21%.\nLevi Strauss & Co is a buy for the bank, which liked its “best-in-class heritage positioning.” “LEVI is emerging from the pandemic with a better-positioned US wholesale marketplace, a more agile organization with increased digital tools and a faster go-to-market,” Goldman said. Its 12-month price target is $36, a potential upside of 25%.\nMedia\nGoldman started covering concert promoter Live Nation Entertainment on July 15. “We initiate coverage on Live Nation (“LYV”) with a Buy rating and 12-month price target of $110, implying 35% total potential return,” the bank said. Goldman expects an uptick inlive events after the pandemicand sees growth opportunities in high-margin merchandise and VIP experiences.\nThe bank also likes audio firm iHeartMedia, Inc., calling it a “most undiscovered” stock, and “the leading multi-platform audio media company in the U.S.” “We initiate coverage on iHeartMedia (“IHRT”) with a Buy rating and a 12-month price target of $32, representing 25% total potential return,” the analysts said in a July 15 research note.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":805662358,"gmtCreate":1627877029374,"gmtModify":1703497024004,"author":{"id":"3581548481060535","authorId":"3581548481060535","authorIdStr":"3581548481060535","name":"Butt3rc00ki3","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581548481060535"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/805662358","repostId":1125617093,"repostType":4,"repost":{"id":"1125617093","pubTimestamp":1627875620,"share":"https://ttm.financial/m/news/1125617093?lang=&edition=fundamental","pubTime":"2021-08-02 11:40","market":"us","language":"en","title":"Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside","url":"https://stock-news.laohu8.com/highlight/detail?id=1125617093","media":"CNBC","summary":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health ","content":"<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs picks new stocks to buy from tech to health — some with over 100% upside\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 11:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"S":"SentinelOne, Inc","LULU":"lululemon athletica","AMAM":"Ambrx Biopharma Inc","LYEL":"Lyell Immunopharma, Inc.","TASK":"TaskUs Inc.","ZM":"Zoom","IS":"IronSource Ltd","02618":"京东物流","LYV":"Live Nation Entertainment","PVH":"PVH Corp","RL":"拉夫劳伦","02171":"科济药业-B","LEVI":"李维斯","IHRT":"iHeartMedia, Inc.","GS":"高盛"},"source_url":"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1125617093","content_text":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is buy-rated on about 45 — and some have a potential upside of over 100%.\nGoldman’s analysts initiated coverage on newly-listed companies that debuted on the stock market in the past few months, and also started providing research on some big-name apparel and media brands. Here’s a selection.\nHealth care\nU.S. insurance firm Bright Health Group, which operates insurance tech software as well as a platform connecting patients with health providers is buy-rated by the bank and raised nearly $1 billionin an initial public offering (IPO) in May. Goldman said it sees more than 100% upside to the share price from its current levels over 12 months, while trading at a “healthy” discount to other rapidly-growing insurers, according to a July 19 research note.\nGoldman also likes Ambrx Biopharma Inc, a cancer biotech firm, for its “pioneering research”, “unique and differentiated platform technology” and partnerships with pharmaceuticals companies such as Bristol Myers Squibb. The bank’s 12-month price target is $53, representing a 148.8% potential upside, the analysts said in a July 13 research note.\nHealth tech company Convey Holding Parent, Inc., which counts the likes of U.S. government insurance plan Medicare as a customer, is a buy for the bank. “We believe Convey differentiates itself from competitors as a provider of purpose-built healthcare IT software and services to government-sponsored health plans,” Goldman’s analysts wrote in a July 11 research note. The bank’s 12-month price target is $21, representing a potential 112.6% upside.\nLyell Immunopharma, Inc., which develops cancer therapies, is also buy-rated by the analysts. “We are encouraged by the preclinical data seen to-date and the experienced management team and note multiple programs are set to enter the clinic with first-in-human data next year,” Goldman’s analysts said in a July 12 research note. The bank’s 12-month price target is $30, representing a potential upside of 88.9%.\nOther new healthcare stocks Goldman picked include Chinese biotech firm CARSGEN-B, with a 12-month price target of 48.72 Hong Kong dollars ($6.25) — a potential upside of 62.7% — and Chinese firm AmoyDx, with a 12-month price target of 140 yuan renminbi ($21.52), a potential upside of 66.7%.\nTechnology\nDigital support company TaskUs Inc. is buy-rated, with Goldman giving it a 12-month price target of $61, a potential upside of 88.3%. The firm helps manage customer service for the likes of Zoom, which hired the company as the coronavirus pandemic struck in 2020. “We believe there is potential, given its historically high net retention rate, for it to grow above the consensus growth rates of its clients,” the bank’s analysts wrote in a July 6 note.\nGoldman gave IronSource Ltd, a “fast growing mobile ad platform at scaled margins,” a 12-month price target of $11, a potential upside of 23.7%. The company went public in Marchvia a special-purpose acquisition vehicle (SPAC)and the bank said it would benefit from growth in mobile apps and also liked its game development arm Sonic Publishing.\nSentinelOne, Inc, which debuted on the New York Stock Exchange in June and wasthe highest-valued cybersecurity IPO ever, is also buy-rated by the bank. Goldman described it as “a best of breed, founder-led XDR [extended detection and response] leader in one of the most attractive segments within Security Software,” in a July 25 research note. The bank gave the stock a 12-month price target of $57, a potential upside of 22.4%.\nGoldman also picked “leading” Chinese firm JD LOGISTICS— which became a separate entity to retail giant JD.com in 2017 — andlisted on the Hong Kong stock exchange in May. Goldman expects it to double its market share by 2025, growing via investments in supply chain technology, overseas expansion and additions to its air cargo network. The bank’s 12-month price target is 58.50 Hong Kong dollars, representing a potential upside of 38.3%.\nGoldman also likes Nasdaq-listed Turkish e-commerce giant Hepsiburada, with a 12-month price target of $25.90 — a potential upside of 95% — and Chinese electronics seller AiHuiShou, with a 12-month price target of $20.80, representing a potential upside of 48.1%.\nApparel\nGoldman started covering several apparel stocks this month and said the sector has “macro tailwinds from a strong consumer and supportive discretionary retail spend,” in a July 14 note to investors.\nAthleisure company Lululemon Athletica on Goldman’s conviction list, with the bank describing it as “a leader in driving online to offline consumer connection,” giving it a buy rating. The analysts likedits $500 million acquisition of fitness screen company Mirror, and gave the stock a $447 12-month target price, a potential upside of 21%.\nLuxury label Ralph Lauren has “potential upside” from digital sales via its own websites, according to Goldman, which is “upbeat” about the company’s turnaround, and it gave it a buy rating. The bank’s 12-month price target is $147, a potential upside of 28%.\nGoldman is also buy-rated on Calvin Klein owner PVH Corp, due to the company’s e-commerce focus, new management and pandemic restructuring, expecting the firm to provide “stronger” margins. The bank gave the stock a 12-month price target of $127, a potential upside of 21%.\nLevi Strauss & Co is a buy for the bank, which liked its “best-in-class heritage positioning.” “LEVI is emerging from the pandemic with a better-positioned US wholesale marketplace, a more agile organization with increased digital tools and a faster go-to-market,” Goldman said. Its 12-month price target is $36, a potential upside of 25%.\nMedia\nGoldman started covering concert promoter Live Nation Entertainment on July 15. “We initiate coverage on Live Nation (“LYV”) with a Buy rating and 12-month price target of $110, implying 35% total potential return,” the bank said. Goldman expects an uptick inlive events after the pandemicand sees growth opportunities in high-margin merchandise and VIP experiences.\nThe bank also likes audio firm iHeartMedia, Inc., calling it a “most undiscovered” stock, and “the leading multi-platform audio media company in the U.S.” “We initiate coverage on iHeartMedia (“IHRT”) with a Buy rating and a 12-month price target of $32, representing 25% total potential return,” the analysts said in a July 15 research note.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":805683428,"gmtCreate":1627875949964,"gmtModify":1703497005694,"author":{"id":"3580375840418108","authorId":"3580375840418108","authorIdStr":"3580375840418108","name":"yani","avatar":"https://static.tigerbbs.com/1874321b512b0390126a7a442cf8f470","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3580375840418108"},"htmlText":"Like and comment pls","listText":"Like and comment pls","text":"Like and comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/805683428","repostId":1125617093,"repostType":4,"repost":{"id":"1125617093","pubTimestamp":1627875620,"share":"https://ttm.financial/m/news/1125617093?lang=&edition=fundamental","pubTime":"2021-08-02 11:40","market":"us","language":"en","title":"Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside","url":"https://stock-news.laohu8.com/highlight/detail?id=1125617093","media":"CNBC","summary":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health ","content":"<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs picks new stocks to buy from tech to health — some with over 100% upside</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs picks new stocks to buy from tech to health — some with over 100% upside\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 11:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"S":"SentinelOne, Inc","LULU":"lululemon athletica","AMAM":"Ambrx Biopharma Inc","LYEL":"Lyell Immunopharma, Inc.","TASK":"TaskUs Inc.","ZM":"Zoom","IS":"IronSource Ltd","02618":"京东物流","LYV":"Live Nation Entertainment","PVH":"PVH Corp","RL":"拉夫劳伦","02171":"科济药业-B","LEVI":"李维斯","IHRT":"iHeartMedia, Inc.","GS":"高盛"},"source_url":"https://www.cnbc.com/2021/08/02/goldman-sachs-picks-new-stocks-to-buy-from-tech-to-health.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1125617093","content_text":"Goldman Sachs has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is buy-rated on about 45 — and some have a potential upside of over 100%.\nGoldman’s analysts initiated coverage on newly-listed companies that debuted on the stock market in the past few months, and also started providing research on some big-name apparel and media brands. Here’s a selection.\nHealth care\nU.S. insurance firm Bright Health Group, which operates insurance tech software as well as a platform connecting patients with health providers is buy-rated by the bank and raised nearly $1 billionin an initial public offering (IPO) in May. Goldman said it sees more than 100% upside to the share price from its current levels over 12 months, while trading at a “healthy” discount to other rapidly-growing insurers, according to a July 19 research note.\nGoldman also likes Ambrx Biopharma Inc, a cancer biotech firm, for its “pioneering research”, “unique and differentiated platform technology” and partnerships with pharmaceuticals companies such as Bristol Myers Squibb. The bank’s 12-month price target is $53, representing a 148.8% potential upside, the analysts said in a July 13 research note.\nHealth tech company Convey Holding Parent, Inc., which counts the likes of U.S. government insurance plan Medicare as a customer, is a buy for the bank. “We believe Convey differentiates itself from competitors as a provider of purpose-built healthcare IT software and services to government-sponsored health plans,” Goldman’s analysts wrote in a July 11 research note. The bank’s 12-month price target is $21, representing a potential 112.6% upside.\nLyell Immunopharma, Inc., which develops cancer therapies, is also buy-rated by the analysts. “We are encouraged by the preclinical data seen to-date and the experienced management team and note multiple programs are set to enter the clinic with first-in-human data next year,” Goldman’s analysts said in a July 12 research note. The bank’s 12-month price target is $30, representing a potential upside of 88.9%.\nOther new healthcare stocks Goldman picked include Chinese biotech firm CARSGEN-B, with a 12-month price target of 48.72 Hong Kong dollars ($6.25) — a potential upside of 62.7% — and Chinese firm AmoyDx, with a 12-month price target of 140 yuan renminbi ($21.52), a potential upside of 66.7%.\nTechnology\nDigital support company TaskUs Inc. is buy-rated, with Goldman giving it a 12-month price target of $61, a potential upside of 88.3%. The firm helps manage customer service for the likes of Zoom, which hired the company as the coronavirus pandemic struck in 2020. “We believe there is potential, given its historically high net retention rate, for it to grow above the consensus growth rates of its clients,” the bank’s analysts wrote in a July 6 note.\nGoldman gave IronSource Ltd, a “fast growing mobile ad platform at scaled margins,” a 12-month price target of $11, a potential upside of 23.7%. The company went public in Marchvia a special-purpose acquisition vehicle (SPAC)and the bank said it would benefit from growth in mobile apps and also liked its game development arm Sonic Publishing.\nSentinelOne, Inc, which debuted on the New York Stock Exchange in June and wasthe highest-valued cybersecurity IPO ever, is also buy-rated by the bank. Goldman described it as “a best of breed, founder-led XDR [extended detection and response] leader in one of the most attractive segments within Security Software,” in a July 25 research note. The bank gave the stock a 12-month price target of $57, a potential upside of 22.4%.\nGoldman also picked “leading” Chinese firm JD LOGISTICS— which became a separate entity to retail giant JD.com in 2017 — andlisted on the Hong Kong stock exchange in May. Goldman expects it to double its market share by 2025, growing via investments in supply chain technology, overseas expansion and additions to its air cargo network. The bank’s 12-month price target is 58.50 Hong Kong dollars, representing a potential upside of 38.3%.\nGoldman also likes Nasdaq-listed Turkish e-commerce giant Hepsiburada, with a 12-month price target of $25.90 — a potential upside of 95% — and Chinese electronics seller AiHuiShou, with a 12-month price target of $20.80, representing a potential upside of 48.1%.\nApparel\nGoldman started covering several apparel stocks this month and said the sector has “macro tailwinds from a strong consumer and supportive discretionary retail spend,” in a July 14 note to investors.\nAthleisure company Lululemon Athletica on Goldman’s conviction list, with the bank describing it as “a leader in driving online to offline consumer connection,” giving it a buy rating. The analysts likedits $500 million acquisition of fitness screen company Mirror, and gave the stock a $447 12-month target price, a potential upside of 21%.\nLuxury label Ralph Lauren has “potential upside” from digital sales via its own websites, according to Goldman, which is “upbeat” about the company’s turnaround, and it gave it a buy rating. The bank’s 12-month price target is $147, a potential upside of 28%.\nGoldman is also buy-rated on Calvin Klein owner PVH Corp, due to the company’s e-commerce focus, new management and pandemic restructuring, expecting the firm to provide “stronger” margins. The bank gave the stock a 12-month price target of $127, a potential upside of 21%.\nLevi Strauss & Co is a buy for the bank, which liked its “best-in-class heritage positioning.” “LEVI is emerging from the pandemic with a better-positioned US wholesale marketplace, a more agile organization with increased digital tools and a faster go-to-market,” Goldman said. Its 12-month price target is $36, a potential upside of 25%.\nMedia\nGoldman started covering concert promoter Live Nation Entertainment on July 15. “We initiate coverage on Live Nation (“LYV”) with a Buy rating and 12-month price target of $110, implying 35% total potential return,” the bank said. Goldman expects an uptick inlive events after the pandemicand sees growth opportunities in high-margin merchandise and VIP experiences.\nThe bank also likes audio firm iHeartMedia, Inc., calling it a “most undiscovered” stock, and “the leading multi-platform audio media company in the U.S.” “We initiate coverage on iHeartMedia (“IHRT”) with a Buy rating and a 12-month price target of $32, representing 25% total potential return,” the analysts said in a July 15 research note.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5399931,"gmtCreate":1627876278721,"gmtModify":1663231808738,"authorId":3577450174855100,"author":{"id":3577450174855100,"authorId":3577450174855100,"name":"deneee","avatar":"https://static.tigerbbs.com/f703e6fb26f06667065153b01ab5cdfe","vip":1,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.11.24","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":4,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805683428,"type":1,"supId":0,"prevId":0,"content":"ok","text":"ok","html":"ok"},{"id":5400081,"gmtCreate":1627877585946,"gmtModify":1635162225472,"authorId":4088216255024030,"author":{"id":4088216255024030,"authorId":4088216255024030,"name":"dotdot112","avatar":"https://static.tigerbbs.com/305b55c5fda3f8c47f2ae77d43f75e28","vip":1,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.28","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805683428,"type":1,"supId":0,"prevId":0,"content":"[Strong]","text":"[Strong]","html":"[Strong]"}],"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":210,"commentSize":17,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}